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1 INTRODUCTION 
Adenylosuccinate synthetase (ADSS) catalyzes the reaction: 
Mo2+ 
GTP + IMP + L-aspartate # GDP + P,- + adenylosuccinate. 
This reaction is the first committed step in the formation of AMP from IMP in the 
de novo purine biosynthetic pathway. The reaction was first shown to occur in rabbit 
bone marrow by Abrams and Bently [1] in 1955. In 1956 Lieberman [2] demonstrated 
that this reaction occured in Esherichia coli. Carter and Cohen [3] [4] found the same 
reaction in yeast extracts. 
Figure 1.1 outlines the substrates and enzymes involved in the purine nucleotide cy­
cle. IMP is converted to AMP in a two step process similar to the conversion of citrulline 
to arginine and 5-aminoimidazole-4-carboxylate ribonucleotide to 5-aminoimidazole-4-
carboxamide ribonucleotide. The second enzyme in the conversion of IMP to AMP, 
adenylosuccinate lyase, is a dual function enzyme catalyzing the cleavage of adenylosuc­
cinate and 5-aminoimidazole-4-N-succinocarboxamide ribonucleotide. 
ADSS activity has been found in bacteria, plants, and animals [5]. The highest levels 
of activity have been observed in skeletal and cardiac muscle and the testes. Mammalian 
ADSS exists as two isozymes, one acidic (pl=5.9) and one basic (pl=8.9) [6] [7] [8]. It has 
been suggested that ADSS activity is low in normal tissues, undergoing rapid renewal, 
and high in proliferating tissue [5]. However, it has been shown that liver and kidney-
derived tumor cells have a higher specific activity regardless of growth rate. Jackson 
et al. [9] demonstrated that neonatal liver contains low levels of ADSS that, within 
2 
one month after birth, rise to adult levels. The conclusion drawn from these studies is 
that ADSS levels are not related to the growth rate of the cells, rather they seem to be 
dependent on the malignant transformation. 
Since the previous studies were performed on partially purified enzyme, Matsuda et 
al. [10] measured the levels of the acidic and basic mammalian isozymes. It was found 
that normal liver had about 60% total activity in the acidic isozyme and 40% in the 
basic, whereas regenerating liver contained 80% total activity in the acidic and 20% in 
the basic isozyme. The total activity in each case was approximately the same. This 
study provides evidence supporting the idea that ADSS activity is not related to cell 
growth rate. 
ADSS from yeast Saccharomyces cerevisiae has been shown to bind a T-rich strand 
of an autonomously replicating sequence [11]. The synthetase was found to bind the 
sequence: 
5' - ATTTATGTTTT - 3'. 
The physiological consequences of this binding has yet to be determined. 
1.1 Substrates and Inhibitors 
Like most enzymes at a regulatory point in a metabolic pathway, the substrate 
binding sites on ADSS are quite specific. Table 1.1 lists the Km values for various 
ADSS. The Km for GTP is generally low, except for rat enzyme. It has been suggested 
that the differences in Km are due to the use of imidazole-HCl buffer [5]. The Km for IMP 
is low for the acidic isozyme and bacterial enzyme, the muscle enzyme has a higher Km 
for IMP. Chicken derived muscle and liver enzymes have lower Km values for aspartate 
than other sources listed. 
Table 1.2 lists the Michealis constants of substrate analogues for ADSS from E. coli. 
Hydroxylamine is the only known compound that ADSS will use in place of aspartate 
3 
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Figure 1.1 Outline of the reactions involved in the purine nucleotide cycle. 
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[2]. It is thought that ADSS forms 6-N-hydroxyl-AMP when hydroxylamine is present. 
2'dIMP and /3-D-arabinsyl-IMP have been shown to used by ADSS in place of IMP in 
rabbit skeletal muscle [31], Replacement of GTP by dGTP gave approximately 40% of 
the standard reaction rate [23]. When GTP7S replaced GTP in the reaction mixture a 
12.5-fold decrease in maximum velocity was observered [32]. 
A divalent metal cation is required for ADSS activity [2] [7] [23] [25] [31]. Mg^"^ is the 
most effective activator. Mn^''",Ca^'^, Co^+, and Cu^"*" will activate the enzyme, but to a 
lesser degree. ADSS from Azotobacter vinelandii has been extensively studied regarding 
metal interaction [32] [33]. The results of this work suggest that ADSS does not bind 
Mg^"*" at a definitive site on the enzyme. Therefore, it was speculated that Mg^"*" is 
bound to the phosphate oxygens of GTP. Kang and Fromm investigated the activity 
as a function of Mg^+ concentration for E. coli ADSS [34]. They found a sigmoidal 
increase in ADSS activity as the Mg^""" concentration increased. A Hill plot showed that 
there were two Mg^""" ions necessary for full ADSS activity. They have suggested that 
Mg^"*" could be coordinated to aspartate and bind to the enzyme as an aspartate-Mg^"*" 
complex. Thus, there could be 2 Mg^+, one associated with the /3 and 7 phosphates of 
GTP and the other in the Mg^'''-aspartate complex. 
Various compounds have been tested to investigate possible ADSS inhibition. ADSS 
is subject to feedback inhibition by AMP, GDP, GMP, and adenylosuccinate. Kj s for 
AMP range from 10 to 3000 /xM [14] [17] [21] [32]. GDP and GMP have K; s from 5 to 
30 fiM [13] [16] [17] [21] [35] , adenylosuccinate, also a strong inhibitor, has a Ki similar 
to GDP and GMP [13] [16] [17]. Some anions have also been shown to inhibit ADSS, 
including N0J,SCN~, Cl~,I~,Br~, and HCOj [16] [35] [36]. NO3 has been shown to be 
a synergistic inhibitor with GDP [16] and is thought to bind to the same site as the 7 
phosphate of GTP. Table 1.3 lists the kinetic constant and type of inhibition of E. coli 
ADSS by several compounds. Figure 1.2 shows the chemical structures of the substrates 
and some inhibitors of ADSS. Hadacidin, alanosine, and succinate resemble aspartate. 
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Table 1.1 K^values for various Adenylosuccinate synthetases ". 
Source ASP 
K„(/iM) 
IMP GTP Reference 
E. coli 100 30 40 [2] 
980 54 38 [12] 
350 20 10 [13] 
270 54 48 [14] 
260 200 31 [15] 
A. vinelandii 500 13 15 [16] 
B. subtilis 680 34 73 [17] 
S. pombe 1500 200 20 [18] 
Human placenta 950-1160 37-70 31-72 [19] 
Walker carcinoma 381 30 16 [20] 
Novikoff ascites 840 12 12 [21] 
550 16 75 [22] 
Pig brain 230 47 11 [20] 
Chicken muscle 30 171 12 [20] 
Chicken liver 20 20 17 [20] 
Rabbit muscle 300 200 10 [23] 
290 107 12 [20] 
Rat heart 380 167 18 [24] 
Rat liver(acidic) 1470 320 130 [6] 
360 30 15 [20] 
Rat liver(basic) 330 690 90 [6] 
Rat muscle 250 700 380 [25] 
300 200 10 [26] 
360 200 4 [7] 
Wheat germ 430 90 — [27] 
Leishmania donovani 430 12 23 [28] 
Yoshida sarcoma ascites 980 410 70 [29] 
Ehrlich ascites 50 30 100 [30] 
"Adopted from reference [5] 
Table 1.2 Michaelis constants for substrate analogues. 
Substrate Analogue Km(/iM) Reference 
2'-dIMP 260 [31] 
j0-D-arabinosyl-IMP 850 [31] 
dGTP 300 [23] 
GTP-7S 5 [32] 
6 
Table 1.3 Type of inhibition and kinetic properties of various inhibitors of 
adenylosuccinate synthetase. 
Inhibitor ASP IMP GTP 
Ki 
fiM 
AMP noncompetitive competitive noncompetitive 95 [14] 
GMP noncompetitive competitive competitive 74,92[14] 
GDP noncompetitive noncompetitive competitive 12[13] 
ppGpp noncompetitive noncompetitive competitive 50[37] 
GppNp noncompetitive noncompetitive competitive 15[16] 
nitrate noncompetitive noncompetitive competitive -[16] 
adenylosuccinate noncompetitive competitive noncompetitive 5[13] 
hadacidin competitive noncompetitive noncompetitive 0.3[16] 
maleate competitive noncompetitive noncompetitive 900[16] 
phosphate competitive noncompetitive noncompetitive 5000[16] 
thiophosphate competitive noncompetitive noncompetitive 12000[16] 
alanosine" noncompetitive competitive noncompetitive 0.228[38] 
succinate competitive noncompetitive noncompetitive 7500[13] 
6-mercaptopurine 
ribonucleotide noncompetitive competitive noncompetitive 10[13] 
"Alanosine can be converted to alanosyl-AICOR (See text) which is thought to be the inhibitor 
of ADSS rather than alanosine itself. Alanosine is a weak noncompetitive inhibitor with respect to 
all substrates. 
Both hadacidin and alanosine have low K; 's, however only hadacidin is competitive with 
respect to aspartate. Alanosine is believed to inactivate ADSS through alanosyl-5amino-
4-imidazole carboxylic acid ribonucleotide, (alanosyl-AICOR) which is competitive with 
respect to IMP. Succinate is a competitive inhibitor with respect to aspartate, but has 
a much higher Kj than hadacidin. 6-mercaptopurine ribonucleotide is a competitive 
inhibitor with respect to IMP with a relatively low K; (ss 10 /xM) [13] [16]. 
A variety of glycolytic intermediates have been shown to inhibit ADSS. Fructose-1,6-
bisphosphate caused significant inhibition at 50/iM and was a noncompetitive inhibitor 
with respect to all substrates [35]. 2,3-Bisphosphoglycerate, 3-phosphoglycerate, 2-
phosphoglycerate, and phosphoenolpyruvate have been shown to inhibit ADSS at 20;iM 
[35]. Ogawa et al. [39] demonstrated that the basic isozyme from rat muscle was in­
7 
hibited by fructose-l,6-bisphosphate to a greater extent (Ki =0.6mM) than the acidic 
isozyme (K; =1.6mM). In contrast to Ogawa's work on the rat muscle enzymes, Baugher 
[7] determined the K; to be 130/iM for the rat muscle basic isozyme. Fischer [22] deter­
mined the K; for fructose-l,6-bisphosphate in rabbit cardiac and skeletal muscle enzymes, 
Kj ranging from 50 to 150 /JM . Considering these later studies fructose-1,6-bisphosphate 
could be an important physiological regulator of the muscle enzymes. 
1.2 Mechanism 
Figure 1.3 shows the three proposed mechanisms of ADSS. Scheme I Illustrates the 
one-step "concerted" mechanism proposed by Miller and Buchanan [40]. They proposed 
this mechanism after discovering the reverse reaction occured with arsenate in place of 
phosphate in the cissay buffer. They also found that GDP was absolutely necessary for 
arsenolysis to occur. 
Mechanism II illustrates the 6-phosphoryl IMP - enzyme intermediate reaction. 
Lieberman [2] found, through labeled IMP at the C-6 position, that all was 
converted to inorganic phosphate. No incorporation of ^^P inorganic phosphate into 
GTP was observed when ^^P inorganic phosphate , GDP , IMP , MgCl2 , and ADSS 
were incubated together at 37 °C for 60 minutes. This evidence lead him to propose 
mechanism II involving the formation of the 6 - phosphoryl IMP intermediate and then 
the nucleophilic attack on C-6 by the amino group of aspartate. Fromm [41] , through 
isotope exchange at chemical equilibrium, found that the aspartate - adenylosuccinate 
exchange was « 10 fold higher than the phosphate - GTP exchange. If the substrate 
binding steps are in rapid equilibrium and step II 2 (Figure 1.3) is rate limiting , then 
this result is consistent with mechanism II. 
Mechanism III was proposed by Markham and Reed [32] and involves the tetrahedral 
addition product between IMP and aspartate followed by a phosphorylation and eventual 
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Figure 1.2 Chemical structures of substrates and some inhibitors of adeny­
losuccinate synthetase. 
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break down into products. Evidence supporting this mechanism was gathered from 
studies using GTP-7S in place of GTP. The Km for GTP-7S is 3.5 fold lower than GTP 
with a Vmoi that is 12.5 fold lower. Using UV difference spectra they found that when 
ADSS, GTP-7S , IMP , and aspartate were allowed to react, a difference peak appeared 
around 320nm. These results indica.ted the possibility of 6-thio IMP being formed in 
the reverse reaction using the SPi released from the GTP-7S. This theory was confirmed 
when 2.7mM Mg(acetate), 54 fiM adenylosuccinate, and 29mM SPi in 50mM HEPES 
pH=7.0 were allowed to react for Ihr at 22° C. They found a UV difference peak at 
320nm, characteristic of 6-thio IMP. 6.5 fiC'i of [8^H] GDP was added to a solution 
containing 47mM SPi, 0.2mM GDP, O.lmM adenylosuccinate, 2.0mM Mg(acetate) and 
0.16 /ig of ADSS. After 2hrs at room temperature, the reaction mixture was loaded 
on a PEI-cellulose column. Unlabeled GTP and GDP were also loaded on the column 
and eluted with 2.0M LiCl. Fractions were checked for radioactivity and the ratio of 
GTP/GDP was determined to be 0.76. This indicates there was a substantial amount 
of GTP formed from the [8^H] GDP. Both of these observations are consistent with 
mechanism III. 
Various studies have been performed concerning the binding mechanism of the sub­
strates. It is generally agreed upon that the binding mechanism is random [5]. However, 
equilibrium isotope exchange studies by Cooper et al. [42] demonstrated that IMP and 
GTP had slower exchange rates than aspartate. These results are consistent with the 
finding of Bass et al. [43] concerning the binding of GTP and IMP without aspartate 
present. GTP and IMP binding commits both substrates to product formation, which 
is consistent with aspartate binding after GTP and IMP. Cooper et al. were not able to 
determine if the GTP - IMP intermediate gave raise to a complete phospho-transfer to 
form a 6-phosphoryl-IMP intermedictte or whether another partial transfer intermediate 
was involved. 
COO" 
-00CCH2CH \ . 
H2N .•0._ ? 
GMP 
COO Ribose 5'-P 
H-C-CH„COO 
NH 
III 
+ GDP-Pi-E E-ASP-GTP-IMP 
Ribose 5'-P 
Adenylosuccinate 
Ribose 5'-P 
COO coo 
nil H-C-CH_C00 H-C-CH„COO 
NH -Q 
-E-GDP E-GDP-
Ribose5'-P Ribose 5'-P 
Figure 1.3 Three proposed mechanisms of adenylosuccinate synthetase. 
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1.3 E. coll Adenylosuccinate Synthetase 
The E. coli enzyme has been well characterized and determined to be a homodimer 
with subunit molecular weight of 48,000 [43]. The E. coli enzyme has a high degree of 
identity to mammalian synthetases. There is 40% identity between E. coli ADSS and 
mouse ADSS [44]. Bass et al. engineered a strain of E. coli which overproduces w 14% 
of its total soluble protein as ADSS. Purification of the E. coli enzyme involves three 
main steps, ammonium sulfate precipitation, phenylsepharose hydrophobic interaction 
chromotography, and DEAE high performance liquid chromatography [43]. As previ­
ously discussed, the kinetic constants for purified enzyme have been determined and are 
listed in Table 1.1. 
The amino acid sequence for ADSS from E. coli has been determined [46]. A sequence 
comparision between GTP-binding proteins has revealed consensus sequences that are 
involved in recognition of the phosphoryl moiety and the guanine base [47]. The former 
consisting of the sequence GXXXXGK and latter (N/T)KXD. All ADSS sequenced 
possess these sequences [48] [49] [50] [51] [52] [53]. Table 1.4 lists the results of kinetics 
studies on mutants in the phosphoryl binding sequence [54]. These indicate residues 
12 through 15 and residue 19 are necessary for catalytic activity. Mutating K16 to Q 
resulted in « 50% of wild type activity [55] which is interesting due to the fact that this 
residue is highly conserved among all synthetases. It seems that mutation of K18 to 
R resulted in a slight increase in k^at. Km values for each substrate changed very little 
with mutations of G12, G15, and G17 to valine and K18 to arginine. Mutating 119 to 
threonine and E14 to alanine resulted in ftJ 100-fold increase in Km for GTP and 5-fold 
increase in Km for aspartate respectively. 
Table 1.5 contains the kinetic data for mutants in the guanine base recognition 
sequence [56] [57]. Both mutations of K331 and D333 resulted in a 10-fold increase in 
Km for GTP. The D333 to N mutation resulted in a change in substrate specificity from 
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Table 1.4 Kinetic parameters for wildtype and mutants in the phosphoryl 
binding sequence of adenylosuccinate synthetase from E. coli. 
Protein kcat KmGTP KmIMP KmAsp Reference 
(/sec) i f i M )  (/iM) i f i M )  
Wild-type 1.65 22.1 21 280 [54] 
G12V 0.0072 37.6 37.3 403 [54] 
E14A 0.022 31.2 55 1400 [58] 
G15V 0.00788 68.4 52.3 121 [54] 
K16Q 0.479 23 50.5 308 [58] 
G17V 1.86 36.2 76.8 278 [54] 
K18R 3.32 37 17.6 190 [54] 
I19T 0.73 3570 60 356 [54] 
Table 1.5 Kinetic parameters for wildtype and mutants in the guanine base 
binding sequence of adenylosuccinate synthetase from E. coli. " 
Protein GTP XTP 
kcat(/sec) Km(/^M) kcat(/sec) Km(/^M) 
Wild-type 0.733 22.2 0.0268 388 
D333N 0.111 193 1.14 33.1 
D333E 0.0189 140 0.0523 28.5 
D333Q 0.0179 334 0.0599 54.7 
"Reference [57] 
GTP to XTP (See Figure 1.4). The kcaf and Km for XTP associated with this mutant 
are comparable to the kcat and Km for GTP associated with the wild type enzyme. Thus, 
ADSS from E. coli was converted from GTP utilizing to XTP utilizing. 
Residues in the aspartate binding site have been tentatively identified by site directed 
mutagenesis [59]. Table 1.6 contains the kinetic data associated with the mutations of 
three arginines to leucines in the putative aspartate binding site. R303 to L resulted in 
a 250-fold increase in the Km for aspartate, R304 to L resulted in a 290-fold increase in 
the Km for aspartate and R305 to L caused the Kmfor aspartate to increase 44-fold. All 
mutants had lower activity than the wild type enzyme, but R305 to L had the largest 
decrease, « 0.8% of wild type activity. This mutant also exhibited the smallest increase 
in Km for aspartate. These data indicate that R303, R304, and R305 are important for 
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Table 1.6 Kinetic parameters for wildtype and mutants in the putative as­
partate binding site of adenylosuccinate synthetase from E. coli. 
a 
Mutant kcat K^GTP K^IMP KmAsp 
(/sec) i f i M )  (mM) m) 
Wild-type 1.00 26.2 27.8 230 
R303L 0.13 20.1 35.2 57,400 
R304L 0.18 26.5 29.6 65,700 
R305L 0.008 30.6 30.5 10,000 
''Reference[59] 
aspartate binding and catalysis. 
1.4 Present Study 
The unligated enzyme has been crystallized by the hanging drop method [45]. This 
dissertation describes the X-ray crystal structures of the P2i, P2i2i2iand P3221 crys­
tal forms of adenylosuccinate synthetase from E. coli . These structures will reveal 
substrate binding sites which will lead to a better understanding of the chemical mech­
anism involved in the conversion of IMP to adenylosuccinate. Thus, new inhibitors can 
be developed. Given the high degree of identity between the E. coli enzyme and the 
mammalian enzyme, the structures determined here will serve as a valid model for the 
mammalian synthetase. Adenylosuccinate synthetase has higher activity in malignant 
cells and these new inhibitors could be used as chemotherapeutic agents in the fight 
against cancer. 
1.5 Dissertation Organization 
This dissertation contains a general introduction, four scientific papers, a general 
conclusion and a bibliography. Each scientific paper contains an abstract, introduction, 
materials and methods and results and discussion sections. The bibliography section 
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contains references for each section of the dissertation including the scientific papers 
mentioned above. 
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2 CRYSTAL STRUCTURE OF ADENYLOSUCCINATE 
SYNTHETASE FROM ESCHERICHIA COLI: EVIDENCE FOR 
CONVERGENT EVOLUTION OF GTP BINDING 
DOMAINS 
A paper published in the Journal of Biological Chemistry ^ 
Bradley W. Poland, Mercedes M. Silva, Micheal A. Serra, Yunje Cho, Kyung H. Kim, 
Erica M. S. Harris, and Richard B. Honzatko 
2.1 Abstract 
The structure of the P2i crystal form of adenylosuccinate synthetase from Esherichia 
coli has been determined to a resolution of 2.8A. The refined model for the enzyme 
gives an R-factor of 0.20 and a root-mean-square deviation from expected bond lengths 
and angles of O.OISA and 2.27®, repectively. The dominant structural element of each 
monomer of the homodimer is a central /3-sheet of ten strands. The first nine strands 
of the sheet are mutually parallel with right-handed crossover connections between the 
strands. The 10^'' strand is antiparallel with respect to the first nine strands. In addition, 
the enzyme has two antiparallel /3-sheets, comprised of two strands and three strands 
each, 11 a-helices and 2 short 3/10-helices. The overall fold of the polypeptide chain 
has not been observed heretofore in any other protein structure. 
^Reprinted with permission of J. Biol. Chem. 1993, 268(34)25334-25342. 
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Residues tentatively assigned to the active site of the enzyme on the basis of chemical 
modification and directed mutation cluster in two separate regions. Gly*^, Gly^®, Gly'^, 
Lys^®, Ile^®, and Lys^^^ lie at one end of a crevice that measures I2A by 30A by I2A 
deep. Lys^^" and Arg^"*^ are not part of this crevice, but instead lie at the interface 
between monomers of the dimer. Lys^"*® makes a salt link with Asp^^^ of a monomer 
related by molecular symmetry and Arg'"^' binds to the carbonyl of the same Asp^^^. 
Superposition of the p21 ras protein [60] onto the synthetase reveals significant cor­
respondences between side chains of the two proteins. Residues which interact with 
GTP in the p21 ras protein have structurally equivalent residues in the synthetase. The 
GTP molecule, when transformed to the coordinate frame of the synthetase, falls into 
the crevice defined by studies in directed mutation. We suggest that the similarities in 
the GTP binding domains of the synthetase and the p21 ras protein are an example of 
convergent evolution of two distinct families of GTP-binding proteins. 
2.2 Introduction 
Adenylosuccinate synthetase (IMP:L-aspartate ligase (GDP-forming), EC 6.3.4.4) 
governs the first committed step in the de novo synthesis of AMP. The enzyme hydrolyzes 
one molecule of Mg^'^'-GTP in the synthesis of adenylosuccinate from aspartate and IMP: 
GTP + IMP + L-aspartate # GDP -|- P, + adenylosuccinate 
The chemical mechanism proposed for the synthetase by Lieberman [2], which calls for 
the initial formation of an intermediate of 6-phosphoryl IMP, enjoys considerable support 
in the literature [12] [41] [42] [61]. In the Lieberman mechanism, the 7-phosphate of GTP 
is transfered to the 6-oxygen of IMP, whereupon the amino group of aspartate displaces 
phosphate from the 6-carbon of the intermediate. The enzyme from various sources is 
subject to feedback inhibition by AMP, adenylosuccinate, GDP, and GMP [14] [17] [19] 
[21]. Stayton et al. [5] have reviewed much of the literature relevant to the synthetase. 
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The synthetase from E. coli is a dimer of identical polypeptide chains. The relative 
molecular weight of the polypeptide is 48,000 [46]. The E. coli enzyme has at least 40% 
sequence identity to the synthetase from other sources [62] [63] [64] [65]. Thus, the fold 
of the polypeptide chain of the enzyme from E. coli should serve as an approximate 
model for the synthetase from many sources, including mammals. Furthermore, all of 
the adenylosuccinate synthetases sequenced thus far possess sequence elements which 
putatively bind to the phosphates and the base of GTP [48] [49] [50] [51] [52] [53]. 
Similar sequences appear in the family of p21 ras proteins and EF-Tu from E. coli [60] 
[66] [67] 
Below we present the crystal structure of adenylosuccinate synthetase from E. coli at 
a resolution of 2.8A. Although the synthetase and the p21 ras protein differ significantly 
in their folding topologies, the synthetase has structural elements that correspond closely 
to regions of the ras protein which bind GTP. We suggest that this structural corespon-
dence is a consequence of convergent evolution of two distinct families of proteins which 
bind and hydrolyze GTP. 
2.3 Materials and IVIethods 
Adenylosuccinate synthetase was prepared from a genetically engineered strain of E. 
coli that produces approximately 14% of its total soluble protein as the synthetase [43]. 
We employed the isolation procedure of Bass et al. [43], but with the minor modification 
of reversing the order of the chromatography steps. Recoveries of pure enzyme increased 
if phenylsepharose chromatography preceded the HPLC chromatography on a Spherogel-
TSK DEAE 5PW column. We obtained routinely 40 mg of highly purified enzyme 
from 6 liters of fermentation culture. The protein migrates as a single band on SDS-
polyacrylamide gel electrophoresis with an apparent relative molecular weight of 48,000. 
The P2i crystal form of the synthetase is grown by the method of hanging drops 
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[45]. Prior to its use in crystallization, the protein is dialyzed against a solution (pH 
7.7) consisting of imidazole (20 mM), succinate (75 mM) and 2-mercaptoethanol (70 
^1/1). Crystals grow at 20 to 25° C from droplets having initially 3 fil of polyethylene 
glycol 3350 (24% w/w) in imidazole (100 mM, pH 6.4 to 7.2) and 2 fi\ of the dialyzed 
protein solution (20 mg/ml). Water vapor from the droplet is equilibrated against a 
solution of 10 ^1 of saturated NaCl in 500 ^1 of polyethylene glycol solution described 
above. Elongated prisms appeared within two to four days and grew to as large as 1.0 
mm in a week. The unit cell parameters are a=73.26, b=72.18, c=82.90, ^=108.17°. 
Succinate was necessary for the growth of the P2i crystal form, but not for the long 
term stability of the crystals. Succinate was omitted as a component of "mounting" and 
"soaking" buffers in the preparation of derivatives. We do not anticipate the presence 
of bound succinate in the present crystal structure and, indeed, density for a succinate 
molecule has not been located, thus far. 
We prepared derivatives by transferring native crystals from the droplets in which 
they grew to a "mounting/soaking buffer" containing 100 mM imidazole-acetate, pH7.0, 
20% (w/w) polyethylene glycol 3350, 5% 2-methyl-3,4-pentanediol, and the heavy atom 
reagent (KjIIg^ or K2Hg(CN)4) added to a final concentration of 1 mM. After 48 hours, 
crystals were mounted for data collection. Numerous mercurial reagents were tried, 
but only mercury iodide and mercury cyanide produced significant changes in diffrac­
tion intensities without disrupting P2i crystals of the synthetase. Other heavy atom 
reagents (complexes of uranyl, lead, platinum and lanthanides at concentrations of 0.1 
mM to 5mM) either had no effect on diffraction intensities or extinguished all diffraction 
intensities. 
Data were collected from the native and K2Hgl4 derivative crystals on a Hamlin area 
detector in the laboratory of Dr. Martha Ludwig (Dept. of Biophysics, University of 
Michigan, Ann Arbor). Two crystals were used for the native data set; the nominal 
limit of diffraction (where (//cr(/)) = 2) of the native crystal is 2.3A. The native data 
20 
Table 2.1 Data collection statistics. 
Data set 
Number of 
Measurements 
Unique Reflections 
Unique Reflections 
with F> 2(t(F) 
Total possible 
Reflections 
Native " K^Hii? K2Hg(CN)4'' 
174373 
54490 
117265 
37461 
257184 
44467 
38939 20457 16735 
Resolution ® (A) 
55621 
0.068 
2.0 
50188'= 
0.069 
2.6 
4465P 
0.101 
2.7 
"Data collected on a Hamlin area detector in the laboratory of Dr. Martha Ludwig, Dept. of 
Biophysics, University of Michigan, Ann Arbor, MI. 
''Data collected on a Siemens area detector at Iowa State University. 
''Friedel pairs not merged. 
''R.j/m = Ej Ei Uij - (^J>l/Ej Ei Aj, where the index i runs over multiple observations of the 
same intensity, and the index j runs over all crystallographically unique intensities. 
'Values here represent resolution limits for data collection. The resolution range at which 
(//(7-(/)) = 2 is 2.3A, 2.6A, and 2.7A for the native, mercury iodide derivative and the mercury 
cyanide derivative, respectively. 
set is 98% complete to 2.0A resolution. However, only data to 2.8A resolution were used 
in the generation of electron density maps and in the refinement reported here. Friedel 
pairs were collected for the mercury iodide derivative on the Hamlin detector as well. 
Derivative crystals decayed twice as rapidly as did native crystals; a total of 9 crystals 
were used in order to obtain an anomalous data set to the diffraction limit (2.6A) of the 
mercury iodide derivative. An anomalous data set to 2.7k resolution was measured from 
three crystals modified by mercury cyanide. Data for the mercury cyanide derivative 
were collected on a Siemens area detector at Iowa State University. For all crystals 
used in data collection, decay of diffraction intensities at the highest resolution range 
averaged no more than 15%. Statistics for the native and derivative data sets appear in 
Table 2.1 . 
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Our initial attempt to determine the X-ray structure failed. That attempt was based 
on phases from the mercury iodide derivative alone (single isomorphous replacement 
with anomalous scattering (SIRAS) figure-of-merit, 0.48 to 2.8A resolution), followed by 
density averaging with respect to the molecular twofold axis. The failure stemmed from 
the poor quality of the phase information at high resolution, rather than an error in the 
noncrystallographic operator or in the averaging process. The averaged electron density 
map at 2.8A resolution did not exhibit recognizable elements of secondary structure. 
Averaged maps at 4.0A resolution based on the same phase set did reveal, however, 
a-helices of appropriate right-handed twist. 
We pursued two avenues in order to enhance the phase information in the resolution 
range of 4.0 to 2.8A. First, we observed elongated cross peaks in the Patterson map 
based on coefficients of (iFjjgijI — |Fnai,„e|)^5 which we attributed to the presence of 
a single iodine atom associated with each of the two principal sites for mercury. The 
inclusion of two iodine atoms in the model for the heavy atom structure of the mercury 
iodide derivative resulted in only a slight improvement in the figure-of-merit from 0.48 to 
0.52. However, the resulting electron density map was substantially improved, revealing 
a sheet structure of at least seven jS-strands. The second step toward improving phase 
information came about through the use of the mercury cyanide data set. Although 
very similar to the mercury iodide derivative, the mercury cyanide derivative had un­
equal occupancies of its two principal sites and no elongation of its cross peaks in the 
isomorphous Patterson map (consistent with the absence of iodine atoms). Using both 
derivatives the figure-of-merit to 2.8A resolution increased to 0.58 and again resulted in 
a noticeable improvement in the electron density map. Parameters for the heavy atom 
sites and the statistics of phasing appear in Tables 2.2 and 2.3. 
We recognized many structural elements (heavy atom sites, side chains, helices and 
/3-strands) in the electron density map, that were related by molecular symmetry. Using 
these symmetry equivalent structures, we calculated a noncrystallographic operator by 
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Table 2.2 Refined heavy atom parameters. 
Heavy Atom x" y" z" Occupancy'' B 
Site Real / Anomalous (A^) 
K2Hgl4 
1 0.16451 0.25000 0.34745 0.82 / 1.31 43.7 
2= 0.19782 0.26249 0.33789 0.68 / 0.85 34.8 
3 0.70965 0.99456 0.89783 0.94 / 1.52 40.8 
4c 0.73150 0.96361 0.89783 0.74 / 0.87 38.3 
5 0.88640 0.45808 0.56940 0.25 / 0.48 46.3 
6 0.34164 0.80749 0.11781 0.34 / 0.59 43.6 
7 0.77828 0.96226 0.92139 0.08 / 0.09 28.1 
8 0.12968 0.26547 0.29563 0.09 / 0.09 6.7 
K2Hg(CN)4 
1 0.17402 0.24154 0.34733 0.55 / 0.81 40.0 
2 0.71385 0.99322 0.89483 0.80 / 1.22 38.4 
"Fractional coordinates. 
''Fraction of the real and anomalous form factors. 
"^Site refined as an atom of iodine. 
the method of Kabsch [68]. The operator was refined directly against the electron density 
map by the method of Cox [69]. The final noncrystallographic operator used in density 
averaging was essentially identical to the one gotten by analysis of a self-rotation function 
[70] [71] and the assumption that the principal sites of the mercury iodide derivative were 
related by molecular symmetry. 
We defined the envelope of the dimer using a program specifically written for the 
Silicon Graphics 4D-25 and averaged electron density about the molecular twofold axis 
using software written by Bricogne [72], but modified for use on the Silicon Graphics 
4D-25. Structure factors calculated from the averaged electron density map gave an 
R-factor of 0.19 to 2.8A resolution. 
A model for the synthetase was built into the averaged map by use of the program 
TOM [73] and a Silicon Graphics 4D-25. The initial model (R-factor of 0.42) was refined 
by simulated annealing using the software XPLOR [74] to an R-factor of 0.21. One cycle 
of XPLOR required approximately 24 hours of computer time on a Silicon Graphics 4D-
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Table 2.3 Phasing statistics from multiple isomorphous replacement. 
Resolution (A) 11.31 7.89 6.05 4.91 4.13 3.57 3.14 2.80 Total 
Number of 
Measurements 239 568 1036 1613 2431 3493 4530 5354 19264 
Mean Figure 
of Merit® 0.81 0.81 0.80 0.74 0.68 0.62 0.54 0.44 0.58 
K2Hgl4 
Rms Heavy 
Atom F'' 198. 164. 130. 106. 88.0 73.6 59.5 46.2 80.8 
Rms ResiduaP 41.1 39.3 33.9 34.8 46.8 41.2 35.2 31.9 7.27 
Anonmalous 
Rms Difference'' 45.6 36.8 27.8 25.3 22.9 20.4 19.4 20.3 24.8 
Calculated 
Rms Difference 34.1 31.4 25.2 20.5 16.9 13.8 11.3 8.57 15.0 
Weighted 
Rms Residual® 19.7 15.1 14.8 16.9 17.6 16.7 16.7 19.0 16.9 
Phasing Power 4.82 4.18 3.85 3.05 1.88 1.78 1.69 1.45 2.17 
K2Hg(CN)4 
Rms Heavy 
Atom F*" 105. 96.4 86.6 75.6 63.6 52.3 41.1 31.8 54.4 
Rms ResiduaP 51.4 42.8 28.3 38.6 45.9 41.0 34.5 28.8 36.4 
Anonmalous 
Rms Difference'^ 29.6 24.1 19.5 18.9 18.3 19.9 21.4 23.8 19.8 
Calculated 
Rms Difference 15.5 16.5 16.0 13.5 11.4 9.39 7.04 5.16 9.34 
Weighted 
Rms Residual® 23.2 19.0 13.7 14.7 14.1 16.0 19.1 22.0 16.3 
Phasing Power 2.04 2.25 3.06 1.96 1.39 1.28 1.19 1.10 1.49 
"Calculated according to the definition of Blow and Crick (1969). 
''Root mean square modulus of the structure factor for heavy atoms. 
"^Root mean square difference in the moduli of observed and calculated structure factors for the 
derivative. The calculated structure factor for the derivative is |Fp|expiaM/fl + |Fjf |expia/f,where 
|FPL and |Fh| are the moduli of the structure factors for the native crystal and for heavy atoms of 
a particular derivative, OMIR is the multiple isomorphous replacement phase angle for the structure 
factor and an is the calculated phase angle for the structure factor of the heavy atoms. 
''Root mean square difference in the moduli of Friedel pairs. 
°Root mean square difference in the calculated and observed anomalous signals. 
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35 server. Manual refitting of the model to the density preceded a second cycle of 
refinement, which resulted in the preliminary model reported here. 
2.4 Results and Discussion 
2.4.1 Quality of the Refined Model 
The model for adenylosuccinate synthetase has been deposited with the Protein Data 
Bank, Brookhaven National Laboratory. The sequence used in refinement appears in 
Figure 2.1 and is identical to that published by Wolfe and Smith [46]. Relevant statistics 
for the refined model of the synthetase appear in Table 2.4. A Luzzati [75] analysis infers 
an overall root-mean-square uncertainty in atomic coordinates of approximately 0.25A. 
Although the structure for the protein is reliable for the most part, much work re­
mains in modeling bound waters and regions of disorder. The uncertain areas of the 
structure are primarily loops at the surface of the protein. Residues 42 to 49, 120 to 129, 
299 to 304, and 356 to 363 are associated with weak electron density. The regions of 
uncertainty will probably undergo some revision as the refinement continues. Thus, one 
should regard the conformation of the protein in the areas above, as being an approxima­
tion of the true fold of the polypeptide chain. In addition to the aforementioned surface 
loops, the side chains of Gln^^^ and Asp^^® are disordered. As discussed below, regions 
of disorder may reflect a natural tendency of the protein to undergo a conformational 
change. 
The Ramachandran plot of all residues of the synthetase, excluding regions of uncer­
tainty listed above, appears in Figure 2.2. Only Gln^° of each polypeptide chain of the 
dimer falls significantly outside of the allowed region of the Ramachandran plot. Gln^° is 
in strong density at the beginning of the glycine-rich loop (P-loop) that putatively inter­
acts with the a- and /3-phosphates of GTP (see below). Distances between the C" atom 
of residue 10 and the carbonyl oxygen of residue 9, as well as the atom of residue 10 
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Table 2.4 Refinement statistics for adenylosuccinate synthetase. 
Number of atoms" 8,140 
Number of observations^ 19,943 
R-Factor'^ 0.201 
Average B (A^) 15.2A^ 
Rms deviation from 
ideal bond lenghts O.OICA 
Rms deviation from 
ideal angles 2.27° 
Rms deviation from 
ideal dihedral angles 25.3° 
Rms deviation from 
ideal improper dihedral angles 1.99° 
"Includes hydrogens linked to polar atoms. Atoms of type C, N, 0, and S total to 6636. 
''All data with F> 2o-(F) and in the resolution range of 10 to 2.8A. 
'^R-Factor = l|Fca(cl - |Fo6»t|/5^ |Fo6j1. The starting R-factor was 0.42. 
and the amide nitrogen of residue 11 are approximately 2.8A. The conformation of Gln^® 
is enforced by hydrogen bonds between carbonyl 10 and amide 227, between amide 10 
and OEl of Glu", and between OEl of Gln^" and amide 267. 
2.4.2 Heavy Atom Sites 
The mercury iodide and mercury cyanide derivatives have substantial occupancies at 
the same principal sites. The two derivatives differ only in the relative occupancies of 
the principal sites and in the presence of minor sites. Sites 1 and 3 of the mercury iodode 
derivative (Table 2.2 ) are nearly equal in occupancy, being approximately 2.0A away 
from the S"^ of Cys^^^ of each monomer. The elongation of peaks in the Patterson map 
for the mercury iodide derivative is consistent with a single atom of iodine associated 
with each of the principal mercury sites. The sites for the putative iodine atoms are 
labeled 2 and 4 under the heading for mercury iodide in Table 2.2 . Two minor sites, 
also related by noncrystallographic symmetry, are located approximately 2.5A from the 
of Cys^^"*. Although these two minor sites (numbers 5 and 6 of Table 2.2 ) were 
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Figure 2.1 Amino acid sequence used in the refinement of adenylosuccinate 
synthetase. Single letters correspond to amino acids as estab­
lished by the lUPAC-IUB Commission on Biochemical Nomen­
clature, Biochemistry 9, 3471-3479. 
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refined as single atoms of mercury, each mercury atom probably has at least one iodine 
atom. The remaining sites of the mercury iodide derivative represent positive difference 
density due to conformational changes induced in the protein in the neighbohood of the 
two principal sites for mercury atoms. The mercury cyanide derivative has only the 
two principal sites, which nearly overlap the positions of sites 1 and 3 of the mercury 
iodide derivative. However, unlike the mercury iodide derivative, the occupancies differ 
significantly for the two sites of the mercury cyanide derivative. Enzyme from derivatized 
crystals of the synthetase is not active. Cys^^® is in the hydrophobic core of the enzyme, 
but near a prominent crevice which we believe binds GTP (see below). 
2.4.3 Secondary Structure and Folding Topology 
Residues which belong to helices and /3-strands of the synthetase are listed in Ta­
ble 2.5 . Approximately 39% of all residues have ^ and angles that fall within ±30° of 
the typical values (^=-64°, •0=-4O°) for an a-helix. Those residues at the ends of helices 
which deviate by more than 30° from typical ^ and tj} values were included as part of the 
helix, provided they participated in the hydrogen bonding of the helix. Approximately 
18% of all residues belong to /3-strands. Each residue of a /9-strand makes at least one 
hydrogen bond with a neighboring strand and each )0-strand of the sheet structures of 
the synthetase participates in at least two hydrogen bonds with a neighboring strand. 
None of the cysteines of the synthetase are involved in disulfide linkages, consistent with 
the findings of Dong et al. [67]. The peptide link between Tyr^^® and Pro^^® is in a cis 
conformation. 
The fold of the polypeptide appears in Figures 2.3, 2.4 and 2.5. A central /?-
sheet of 10 strands dominates the structure of the synthetase. The first 9 strands of 
the sheet (strands Bl, B2, B3, B4, B5, B6, B7, BIO, and B14) are mutually parallel. 
The 10"' strand (B15) is antiparallel to the rest. The crossover connections between 
the first nine strands of the sheet are all right-handed, as is typical of parallel /3-sheets 
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Figure 2.2 Distribution of (jyij} angles for the amino acid residues of adenylo­
succinate synthetase. Open triangles represent residues flanking 
a cis petide; open squares represent glycine residues; * repre­
sents all other residues. 
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Table 2.5 Correspondence of secondary structure to the sequence. 
Type and name Sequence spanned 
of element by element 
/3-strand B1 2-7 
a-helix HI 16-26 
/0-strand B2 28-32 
/3-strand B3 65-69 
a-helix H2 76-88 
3/10-helix H2' 92-96 
/3-strand B4 97-99 
a-helix H3 108-120 
a-helix H4 133-142 
3/10-helix H5' 148-152 
a-helix H5 154-176 
a-helix H6 183-199 
/3-strand B5 200-202 
a-helix H7 204-213 
)0-strand B6 217-222 
a-helix H8 245-252 
/3-strand B7 261-268 
;0-strand B8 270-272 
a-helix HQ 285-293 
;0-strand B9 306-308 
a-helix HIO 312-322 
/3-strand BIO 325-330 
;0-strand Bll 337-349 
/3-strand B12 354-355 
/3-strand B13 369-378 
a-helix Hll 393-406 
^-strand B14 411-413 
|9-strand B15 423-425. 
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[76]. The connections between strands B4 and B5, between strands B7 and BIO, and 
between BIO and B14 are large and may represent domains that could move as rigid 
bodies independently of the central )9-sheet. The connection between strands B4 and 
B5 has four a-helices (H3, H4, H5, and H6) and one short span of 3/10-helix (H5'). 
Helix H4 and H5 contribute significantly to contacts between monomers of the dimer. 
The connection between strand B7 and BIO has an antiparallel /3-sheet of two strands 
(B8 and B9) and two a-helices (H9 and HIO). The connection between strands BIO 
and B14 consists of an antiparallel sheet of 3 strands (Bll, B12, and B13) and a helix 
(Hll). Each of the three domains, mentioned above, contribute residues to the walls of 
a deep crevice. Evidence presented below supports the assignment of the active site to 
this crevice. We speculate further that the three domains, or parts of those domains, 
may undergo conformational changes in response to the binding of substrates. 
2.4.4 Active Site as Defined by Studies in Chemical Modification and 
Directed Mutation 
Directed mutation of residues in two regions impairs the catalytic function of the 
enzyme. The directed mutations of Gly^^, Gly^®, and Gly^^ individually to valine and 
Lys^® to arginine have little effect on the Km of GTP, but reduce catalysis by up to 
10,000-fold [54]. Mutation of Ile^® to threonine elevates the for GTP by 100-fold 
and reduces kcat by 1000-fold [54]. The mutation of Lys^^^ to leucine or arginine causes 
a 10-fold increase in Km for GTP [56]. All of the residues mentioned above reside near 
each other in a large crevice (Figure 2.6 ). On the basis of these studies and structural 
correspondences with the p21 ras protein (see below), we suggest that GTP binds to 
this crevice. 
Two other residues important to the function of the enzyme lie at the interface be­
tween monomers of the dimer (Figure 2.7). Pyridoxal phosphate reacts with Lys^^° 
leaving an inactive enzyme [67]. In addition, GTP and IMP protect Lys^''° from modi-
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Figure 2.3 Stereo view of an a-carbon plot of the adenylosuccinate syn­
thetase dimer as viewed perpendicular to its molecular twofold 
axis (top) and into the active site crevice of one of its monomers 
(bottom). The phosphate binding loop of the synthetase is 
drawn in bold lines. Figures 2.4, 2.7, 2.8, 2.9, and 2.10 
adopt one of the above viewing directions. 
32 
P - L O O P  
CETi 
\ 
Figure 2.4 Schematic drawing of a monomer of adenylosuccinate synthetase 
as viewed into its active site crevice. a-Helices are represented 
as cylinders and )0-strands as arrows. Only the ten /S-strands of 
the central sheet of the synthetase axe shown. 
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Figure 2.5 Topology diagram for adenylosuccinate synthetase. Circles rep­
resent a-helices and squares represent /3-strands. 
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fication by pyridoxal phosphate. Mutation of Lys^^° to isoleucine results in an enzyme 
without activity. We observe Lys^^° in a salt-link with the side chain of Asp^^' of the 
monomer related by molecular symmetry. Phenylglyoxal modifies Arg^''^ resulting in 
an inactive enzyme [77]. Again GTP and IMP protect Arg^^^ against modification and 
the mutant Leu^^'^ is inactive. Arg^"*^ is part of a loop between helices H4 and H5' and 
binds to the carbonyl of Asp^^^ from a monomer related by molecular symmetry. Helix 
H4, of which Lys"° is a part, makes several salt-links and hydrogen bonds with the 
symmetry-related helix H4 of the dimer. Thus, at the very least the salt-link between 
Lys^^" and Asp^^^ and the hydrogen bond between Arg^^'^ and the carbonyl of Asp^^^ 
may play a role in maintaining the synthetase in a conformation that will support catal­
ysis. GTP must protect Lys^^° and Arg^^'^ by way of an indirect mechanism, given 
that our tentative location for the GTP binding site is approximately 30A away from 
the vicinity of these two residues. Interestingly, the side chain of Arg^^^ projects into 
the active site crevice of the monomer related by molecular symmetry. Arg^^^ could 
bind IMP and thereby stabilize the interactions of Lys"° and Arg^^^ with Asp^^^ If 
indeed this is the mechanism by which IMP protects Lys^^° and Arg^^^ from modifying 
agents, then a complete active site of the synthetase would require residues from both 
monomers. Active sites comprised of two polypeptide chains have been observed for 
aspartate carbamoyltransferase from E. coli [78] and aspartate aminotransferase [79]. 
2.4.5 Active Site as Defined by Structural Correspondences with GTP 
Binding Proteins 
The consensus sequence of the elements that bind to the phosphates and base of 
GTP are present in adenylosuccinate synthetase from E. coli. Residues 12 to 18 of the 
synthetase have the sequence of the putative "P-loop" (Figure 2.8), an element which 
interacts with the phosphates of nucleoside triphosphates in a wide range of proteins. 
Residues 330 to 334 of the synthetase have the sequence of the putative base binding ele-
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Stereoview of an a-carbon plot of a monomer of adenylosucci­
nate synthetase as viewed into its active site crevice. Positions 
marked with solid circles represent sites of directed mutation 
and/or chemical modification that result in significant changes 
in catalytic activity. Bold lines representregions of the structure 
that are poorly ordered. 
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Table 2.6 Structural correspondence of adenylosuccinate synthetase and the 
p21 ras protein. 
Name of element Sequence spanned Name of element Sequence spanned 
of the synthetase by the element of the p21 ras protein by the element 
;0-strand B1 1-9 ;9-strand /3i 1-9 
"P-loop" 10-15 "P-loop", Ai 10-15 
a-helix HI 16-23 a-helix ai 16-23 
yS-strand B2 28-34 yS-strand ^2 42-36° 
jS-strand B6 216-224 /3-strand Pz 52-58 
yS-strand B7 261-268 ;S-strand (3^ 77-83 
a-helix HIO 314-323 a-helices as and ay 91-101 
/3-strand BIO 325-330 /3-strand Ps 111-116 
guanine guanine 
recognition site 331-334 recognition site, As 117-120 
a-helix Hll 398-407 a-helix a4 127-136 
)3-strand Bll 409-414 )3-strand jSe 138-145 
connecting loop 415-422 connecting loop Aio 146-150 
/3-strand B15 423-431 a-helix as 151-160^ 
"i^-strands of the two structures coincide, but run antiparallelto each other. 
''Axis of helix as coincides with the axis of /?-strand B15. 
ment of proteins that interact with GTP. As noted above directed mutations of residues 
in each of these regions does impair the catalytic function of the synthetase. Although 
the folding topology of adenylosuccinate synthetase is unlike that of other GTP binding 
proteins, for which structural information is available [60] [67] [66], a casual comparison 
of the structure of the GTP complex of the p21 ras protein [60] to the synthetase reveals 
similar structures in the vicinity of the loop which binds the phosphates of GTP. Super­
position of the residues 1 to 25 of the p21 ras protein (which comprises the N-terminal 
/3-strand preceding the "P-loop" and the a-helix followng it) onto the corresponding 
N-terminal region of the synthetase, reveals correspondences between other elememts 
of secondary structure (Table 2.6 and Figure 2.9). Some of the corresponding elements 
between the p21 ras protein and the synthetcise may be coincidental as, for instance, 
all /3-sheets resemble each other to some degree. However, residues which interact with 
GTP in the p21 ras protein, correspond to residues of identical or similar chemical type 
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in the synthetase (Figure 2.10). For instance, the superposition, based only on the N-
terminal regions of the two proteins, brings Gly'^, Gly^®, Lys'®, Lys^^^ and Asp^^® of 
the p21 ras protein into correspondence with Gly^^, Gly^^, Lys^®, Lys^^^ and Asp^^^, 
respectively, of the synthetase. In the p21 ras protein Lys^^^ packs along the base of the 
bound GTP and Asp^^® hydrogen bonds to the exocyclic 2-amino group and the endo-
cyclic N1 of the guanine. Lys^® in the p21 ras protein interacts with the 7-phosphate 
of GTP. The same transformation that superimposes the "P-loops" of the two proteins 
brings the 7-phosphate of the GTP molecule of the p21 ras protein close to of Lys^® 
of the synthetase. Main chain amides of residues 14, 15, 16 and 17 of the synthetase 
are in positions to form hydrogen bonds to the a- and /3-phosphates of the transformed 
GTP molecule, similar to observed interactions of the amides of residues 14 to 17 of the 
p21 ras protein. Ser^^"* of the synthetase may hydrogen bond to the 6-0x0 position of 
the guanine base, assuming the role of the main chain amide of Ala'^® of the p21 ras 
protein. As an alternative, the amides of residues 415 and 416 of the synthetase, both 
of which are poorly ordered, could make hydrogen bonds to the 6-0x0 position of the 
base. Finally, Pro^^^ of the synthetase occupies the same relative position to the GTP 
molecule as does the side chain of Phe^® of the p21 ras protein. The 7-phosphate of 
the transformed GTP molecule lies approximately in the middle of the crevice, leaving 
ample room for additional substrates and cofactors (IMP, aspartate and Mg^"""). On the 
basis of studies in directed mutation and the correspondence in structures of the p21 ras 
protein and the synthetase, we assign the active site of the adenylosuccinate synthetase 
to this crevice. Furthermore, given the different folding topologies of the p21 ras pro­
tein and the synthetase, the similarities in their respective GTP binding domains may 
represent an instance of convergent evolution. 
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Figure 2.7 Stereoview of an a-carbon plot of a dimer of adenylosuccinate 
synthetase as viewed down its molecular twofold axis, showing 
details of the interactions involving Lys^^°, Arg^^^ and Asp^^^ 
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Figure 2.8 Density and model for the "P-loop" of adenylosuccinate syn­
thetase. 
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Figure 2.9 Stereoview of an a-carbon plot of the p21 ras protein (dashed 
lines) superimposed on an a-carbon plot of a monomer of adeny­
losuccinate synthetase (solid lines). The "P-loop" of the syn­
thetase is displayed in bold lines. 
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Figure 2.10 Stereo view of an a-carbon plot of a monomer of adenylosuc­
cinate synthetase as viewed into its active site. The GTP 
molecule is transformed from the p21 ras structure into the 
coordinate frame of the synthetase as described in the text. 
Selected residues close to the transformed GTP molecule are 
shown in detail. 
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2.4.6 Relation of Conformationally Ambiguous Loops to the Active Site 
The regions of structural disorder, noted above, cluster near the putative binding 
crevice of the enzyme (Figure 2.6). Residues 42 to 49 are near the ribose and phosphates 
of the transformed GTP molecule. Conceivably Thr'*^, for which weak electron density 
is present, could bind to one of the hydroxyl groups of the ribose of GTP. His^^ lies 
in strong density near the presumed location of the phosphates of GTP and His®^ lies 
in strong density in an area of the crevice that could accommodate IMP or aspartate 
(Figure 2.10). Residues 298 to 304 are pooly ordered, but Arg^°^ and/or Arg^°^ could 
interact with GTP after a conformational change in the enzyme. In addition, Arg^°®, 
which is associated with strong electron density, approaches the phosphates of GTP. 
Gln^^'^, Thr'*^® and Asp^^® do not belong to any of the disordered loops of the synthetase. 
Nonetheless the side chains of these residues lie close to the putative GTP binding site 
and are disordered also. The loop comprised of residues 121 to 129 is associated with 
weak electron density. Arg^^\ for which strong electron density is present, lies near His®^ 
and projects into the crevice (Figure 2.10). Arg^^^ most notably lies on the N-terminal 
side of helix H4. Helix H4 participates in a complex network of salt links and hydrogen 
bonds with helix H4 of the monomer related by molecular symmetry. Arg^^^ looks like a 
handle that could be grasped by bound substrate, in order to close the "lid" on the active 
site. The "lid" in the case of the synthetase would be the domain comprised of helices 
H3, H4, H5', H5 and H6 (Figure 2.4). Finally, residues 355 to 363 are in weak electron 
density and close to the domain of helices H3, H4, H5', H5 and H6 of the monomer 
related by molecular symmetry. We speculate that conformationally ambiguous regions 
of the synthetase are all involved in anticipated structural changes in the protein upon 
substrate binding. Our speculation is not without precedents. All of the disordered 
regions in the unliganded structures of the aspartate carbamoyltransferase from E. coli, 
for instance, participate in binding substrate analogues or in conformational changes in 
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response to the binding of analogues [78]. 
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3 REFINED CRYSTAL STRUCTURES OF UNLIGATED 
ADENYLOSUCCINATE SYNTHETASE FROM 
ESCHERICHIA COLI 
A paper published in the Journal of Molecular Biology ^ 
M. Mercedes Silva, Bradley W. Poland, Chad R. Hoffman, Herbert J. Fromm and 
Richard B. Honzatko 
3.1 Abstract 
Crystal structures of unligated adenylosuccinate synthetase from Esherichia coli in 
space groups P2i and P2i2i2i have been refined to R-factors of 0.199 and 0.206 against 
data to 2.0 and 2.5 A, respectively. Bond lengths and angles deviate from expected 
values by 0.011 A and 1.7° for the P2i crystal form and by 0.015 A and 1.7° for the 
P2i2i2i crystal form. The fold of the polypeptide chain is dominated by a central /3-
sheet, which is comprised of 9 parallel strands and a lO"' antiparallel strand. Extending 
off of this central /3-sheet are four subdomains. The four subdomains contribute loops of 
residues which are disordered or have high thermal parameters. At least 3 of these loops 
(residues 42-52, 120-131, and 298-304) contribute essential residues to the putative 
active site of the synthetase. In the absence of ligands, much of the active site of the 
synthetase exists in an ill-defined conformational state. 
^Reprinted with permission of J. Mol. Biol., 1995, 254,431-446 
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Two, nearly-independent regions contribute residues to the interface between polypep­
tide chains of the synthetase dimer. A pair of helices (H4 and H5) interact with their 
symmetry-equivalent mates by way of residues which are not conserved amongst the 
known sequences of the synthetase. The second interface region involves conserved 
residues belonging to structural elements which connect strands of the central /3-sheet. 
Residues putatively involved in the binding of IMP lie at or near the interface between 
polypeptide chains of the dimer. 
Of the 4 sequence elements putatively common to all GTP hydrolases, the synthetase 
has only the guanine recognition element and a glycine-rich loop (P-loop). Although the 
base recognition element is essentially identical to those of the p21 ras and Ga proteins, 
the P-loop of the synthetase is extended in size relative to the P-loops of other GTP 
hydrolases. The P-loop has two acid residues (Asp 13 and Glu 14), which are found in 
the P-loops of only the synthetase family. Glu 14 may be involved in the stabilization of 
the enlarged P-loop of the synthetase, whereas Asp 13 may play a role in catalysis and 
in the coordination of Mg^"*". The structural elements of the p21 ras and G^, proteins 
responsible for binding Mg^+ are either absent from the synthetase or unavailable for 
the coordination of metal cations. 
3.2 Introduction 
Adenylosuccinate synthetase (IMP:L-aspartate ligase (GDP-forming), EC 6.3.4.4) 
catalyzes the formation of adenylosuccinate from GTP, IMP, and aspartate in the pres­
ence of Mg^"*": 
GTP + IMP -t- L-aspartate # GDP -f- P,- -1- adenylosuccinate 
According to the proposed mechanism of Lieberman [2], which enjoys considerable sup­
port in the literature [5] [41] [42] [43] [61], the 7-phosphate of GTP is transfered to 
the 6-oxygen of IMP, whereafter the amino group of aspartate displaces phosphate from 
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the 6-phosphoryl-IMP intermediate. The enzyme from various sources, including Es­
cherichia coli, is subject to feedback inhibition by AMP, adenylosuccinate, GDP, and 
GMP [14] [13] [16] [19] [21]. 
All evidence heretofore suggests that the synthetase undergoes significant confor­
mational change in response to nucleotide ligands. Interactions involving the base of 
OTP cause a reorganization of residues involved in the hydrolysis and transfer of the 
7-phosphate of GTP [57]. Conformational changes in the synthetase in response to 
OTP and GDP have been monitored by fluoresence spectroscopy [80]. Furthermore, the 
introduction of GTP or GTP-analogs, along with IMP, disorders crystal forms of the 
unligated enzyme [44]. 
The synthetase from E. coli is a dimer of identical polypeptide chains of 431 amino 
acids with Mr=48,000 [46] [81]. Synthetases from different sources [46] [62] [63] [64] [65] 
[82] [83] [84] show at least 40% overall identity in amino acid sequence. The synthetase 
family have the consensus sequences commonly associated with GTP binding in the 
GTPase superfamily [47] [63] [84]. Furthermore, adenylosuccinate synthetase adopts 
a polypeptide fold similar to that of dethiobiotin synthetase from E. coli, an enzyme 
which couples the hydroylsis of ATP in the conversion of 7,8-diaminopelargonic acid to 
dethiobiotin [85]. Adenylosuccinate Synthetase from yeast [11] binds to T-rich, single-
stranded DNA. However, the physiological consequences of the observed in vitro binding 
of the synthetase to DNA remain unclear. Nonetheless, structural information involving 
the synthetase from E. coli is relevant to enzymes that utilize GTP, such as the p21 ras 
proteins, G-proteins, and the elongation factor Tu. 
Presented here are refined models for the P2i and P2i2i2i crystal structures of 
unligated adenylosuccinate from E. coli at 2.0 and 2.5 A resolution, respectively. The two 
structures represent the conformation of the enzyme in the absence of ligands and thus, 
serve as a reference to the measurement of conformational change in the enzyme in its 
ligand complexes. Furthermore, in contrast to the P2i crystal form, the P2i2i2i crystal 
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form is of particular relevance to studies of synthetase-ligand complexes, as it is stable 
in the presence of analogues of GTP. The two crystal structures are identical to within 
the limits of uncertainty of the coordinates except in four regions, three of which make 
significant contributions to the putative active site of the enzyme. The fourth region 
lies near the active site at the interface between monomers of the synthetase dimer. 
The structures of the unligated enzyme, reported here, in conjuction with preliminary 
structures of the synthetase with GTP and IMP analogs, indicate that the active site 
of adenylosuccinate synthetase from E. coli is comprised largely of elements of poorly 
ordered structure in the absence of active-site ligands. 
3.3 Materials and Methods 
Adenylosuccinate synthetase was prepared from a genetically engineered strain of E. 
coli that produces approximately 14% of its total soluble protein as the synthetase [12]. 
We employed the isolation procedure of Bass et al. [12], but with the modification of 
reversing the order of the chromatography steps. Recoveries of pure enzyme increased if 
phenylsepharose chromatography preceded the HPLC chromatography on a Spherogel-
TSK DEAE 5PW column. We obtained routinely 40 mg of highly purified enzyme 
from 6 liters of fermentation culture. The protein migrates as a single band on SDS-
polyacrylamide gel electrophoresis with an apparent relative molecular weight of 48,000. 
The P2i crystal form of the synthetase is grown by the method of hanging drops 
[45]. Prior to its use in crystallization, the protein is dialyzed against a solution (pH 
7.0) consisting of imidazole (20 mM), succinate (75 mM) and 2-mercaptoethanol (70 
/il/1). Crystals grow at 20 to 25° C from droplets having initially 3 /il of polyethylene 
glycol 3350 (24% w/w) in imidazole (100 mM, pH 6.4 to 7.2) and 2 (A of the dialyzed 
protein solution (20 mg/ml). Water vapor from the droplet is equilibrated against a 
solution of 10 /il of saturated NaCl in 500 /il of polyethylene glycol solution described 
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above. Elongated prisms appeared within two to four days and grew to as large as 1.0 
mm in a week. The unit cell parameters are a=73.26, b=72.18, c=82.90, /3=108.17°. 
The asymmetric unit of the P2i crystal is an entire synthetase dimer. Succinate was 
necessary for the growth of the P2i crystal form, but not for the long term stability of 
the crystals. In mounting crystals of the synthetase for data collection, succinate was 
omitted as a component of a stabilization buffer, which contained 100 mM imidazole-
acetate, pH 7.0, 20% (w/w) polyethylene glycol 3350, 5% 2-methyl-3,4-pentanediol. 
Conditions for the growth of another crystal form of the unligated enzyme were 
discovered by use of the sparse matrix of Jancarik and Kim [86] and the method of 
hanging drops. Droplets contained 2 fil of enzyme solution, dialyzed against imidazole-
succinate buffer as above, and 3 fil of a crystallization buffer, which contained 25% 
(w/w) polyethylene glycol 3350, 100 mM acetic-acid/sodium acetate, pH 5.2, and 200 
mM ammonium acetate. The final pH of the crystallization buffer was 6.5. Wells 
contained 500 fi\ of the crystallization buffer. Crystals of approximately 0.5 mm in all 
dimensions and belonging to the space group P2i2i2i (unit cell parameters a=73.42, 
b=93.63, c=119.47) grew in about one week. The asymmetric unit consists of an entire 
dimer. The crystals from the acetate/polyethylene glycol buffer are different from those 
grown from ammonium sulfate [45], even though they belong to identical space groups. 
Data were collected from native P2i crystals on a Hamlin area detector in the labo­
ratory of Dr. Martha Ludwig (Dept. of Biophysics, University of Michigan, Ann Arbor). 
Two crystals were used for the native data set; the nominal limit of diffraction (where 
(/lcr{I)) = 2) of the P2i crystal form is 2.3 A. The native data set is 98% complete to 
2.0 A resolution (Table 3.1). Data from the P2i2i2i crystal form were collected on a 
Siemens area detector at Iowa State University and were reduced by using XENGEN 
[87]. The data set was 99% complete to 2.5 A resolution (Table 3.1). 
The P2i crystal structure was determined by multiple isomorphous replacement and 
anomalous scattering from two mercurial derivatives, followed by density averaging about 
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Table 3.1 Refinement statistics for adenylosuccinate synthetase. 
P2i P2i2i2i 
crystal form crystal form 
Resolution limit (A) 2.0 2.5 
Number of measurements 174,373 104,085 
Number of unique Refl. 54,490 32,170 
Completeness of data set (%) 98 99 
Completeness of data in 
95(2.0-2.07A) 94(2.5-2.60A) the last resolution shell (%) 
P 0 
^aym 6.8 6.0 
Number of refl. in refinement'' 49130 23699 
Number of atoms'^ 9988 9584 
Number of solvent sites 574 439 
R-Factor*^ 0.199 0.206 
Resolution (A) 5 to 2.0 5 to 2.5 
Mean B (A^) for protein 
chain A 27 28 
chain B 27 23 
Rms deviations 
bond lenghts (A) 0.011 0.015 
bond angles (deg) 1.65 1.70 
dihedral angles (deg) 23.9 24.8 
improper dihedral angles (deg) 1.47 1.64 
"Rtym — Sj Si I < -0 >1 / Z)i ' where i runs over multiple observations of the same 
intensity, and j runs over all crystallographically unique intensities. 
''All data in the resolution ranges indicated. 
•^Includes hydrogens linked to polar atoms. 
^^factor — Y, II ^obs I - I Fcalc II / I] I Fobs |, 1 Fgbs |> 0. 
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the molecular twofold axis. Details of the structure determination of the P2i crystal form 
are in the literature [81]. 
The structure of the P2i2i2i crystal form was determined by molecular replacement 
using the preliminary structure of the P2i crystal form [81] and programs from the 
CCP4 package. Structure factors were calculated for the synthetase dimer in an over­
sized unit cell (space group PI, a=b=c=150 A). The calculated structure factors were 
used in conjuction with the native data collected from the P2i2i2i crystal form in the 
computation of a rotation function [70] [71]. The rotation function revealed a symmetry 
unique peak (a=90.1, )0=12O.O, and 7=184.5) at a level of 11<t. The next highest peak 
in the map appeared at a level of 4<r. After applying the appropriate rotation to the 
coordinates of the original model, a translation function [88] produced a single peak of 
ll<r at x=-25.35, y=-6.03, and z=-32.04. Using XPLOR [74], the rotated and translated 
model was refined as a rigid body against data to 7.0 A resolution. The initial R-factor 
was 0.52 and droped to a final value of 0.35 after four cycles. Rigid body refinement was 
repeated, extending the resolution of the data by increments of 1.0 A to a final resolution 
of 3.0 A. The model was subjected then to a single round of simulated annealing, during 
which the system was heated to 2000° K and then cooled to 300° K in steps of 25° K. The 
R-factor after the initial round of simulated annealing was 0.25 to 3.0 A resolution. 
Refinement of models for the P2i and the P2i2i2i crystal forms involved mannual 
fitting of the model to the electron density, using a Silicon Graphics 4D-25 and the 
program TOM [73], followed by a cycle of refinement using XPLOR on a Silicon Graphics 
4D-35. Constants of force and geometry for the protein came from Engh & Huber [89]. 
In early rounds of refinement both crystal strutures were heated to 2000° K and then 
cooled in steps of 25°K to 300°K. In later rounds of refinement, the systems were heated 
to 1000 or 1500°K, but then cooled in steps of 10°K. After the slow-cooling protocol 
was completed (at 300°K), the models were subjected to 120 steps of conjugate gradient 
minimization, followed by 20 steps of individual B-parameter refinement. Individual B-
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parameters were subject to the following restraints: nearest neighbor, main chain atoms, 
1.5 A^; next-to-nearest neighbor, main chain atoms, 2.0 A^; nearest neighbor, side chain 
atoms, 2.0 A^; and next-to-nearest neighbor, side chain atoms, 2.5 A^. 
Water molecules were added if (i) electron density at a level of 2.5«r was present in 
maps based on Fourier coefficients (|Fobs| — |Fcaic|)e'°'^'' and (2|Fobs| — |Fcaic|)e'""'S and 
(ii) acceptable hydrogen bonds could be made to an existing atom of the model. If after 
refinement a site for a water molecule fell beyond 3.3 A from its nearest neighbor, that site 
was omitted from the model. In addition, water molecules were deleted from the model 
if their thermal parameters exceeded 80 A^. Harmonic restraints (50 kcal/mol) were 
placed on the positions of oxygen atoms of water molecules, in order to allow new water 
molecules to relax by adjustments in orientation. Occupancies of water molecules were 
not refined, because of the high correlation between occupancy and thermal parameters 
for data of a nominal resolution of 2.0-2.5 A. Thus solvent sites with B values between 
50 A^ and 80 A^ probably represent water molecules with occupancy parameters below 
1.0 and thermal parameters substantially lower than those reported from the refinement. 
Side chains were screened for multiple conformations on the basis of the following 
criteria: (i) electron density must be present at a level of at least 2.5o' in maps based 
on Fourier coefficients (|Fobs| — |Fcaic|)e'°'"''' and (2|Fobs| — |Fcaic|)e'°"'S (ii) alterna­
tive conformers must have reasonable contacts with nearby atoms; (iii) each conformer 
must adopt or be close to a conformation with staggered x angles; (iv) electron density 
supporting the conformational disorder must persist in omit-maps. 
3.4 Results and Discussion 
3.4.1 Quality of the refined models 
The models for unligated adenylosuccinate synthetase have been deposited with the 
Protein Data Bank, Brookhaven National Laboratory. The method of Luzzati [75] in-
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Figure 3.1 Amino acid sequence used in the refinement of unligated crystal 
structures of the synthetase. 
20 
40 
60 
80 
100 
120 
140 
160 
180 
200 
220 
240 
260 
280 
300 
320 
340 
360 
380 
400 
420 
431 
53 
dicates an uncertainty in coordinates of 0.25 A. The amino acid sequences used in re­
finement (Figure 3.1) differs from that derived from the DNA sequence [46] at position 
416. The electron density is consistent with a glycine at position 416 instead of as­
partate, as indicated in the DNA sequence. Glycine is present at position 416 in other 
known sequences of the synthetase. Furthermore, sequencing results in conjunction with 
studies in directed mutation [90] put a glycine at position 416 of the E. coli synthetase. 
Segments 121-130 and 298-304 correspond to poorly ordered loops (see below). Here 
we were able to do little more than indicate the course of the polypeptide chain. With 
respect to the loops 121-130 and 298-304, the crystallographic data neither confirm 
nor contradict the DNA sequence. One mistake in the refinement sequence used in the 
preliminary structure [81] was detected. Leu 400 of the preliminary model is infact Lys 
400, consistent with the published DNA sequence. 
The Ramachandran plots for the P2i and P2i2i2i crystal forms appear in Figure 3.2. 
The most apparent outlier is Gin 10, which exists in the same conformation in each of 
the four independent polypeptide chains of the two crystal forms. Additional refinement 
at a resolution of 2.0 A and data from a second crystal form (P2i2i2i) confirms the 
previous interpretation of Poland et al. [81]. The conformation of Gin 10 is enforced by 
three hydrogen bonds between carbonyl 10 and amide 227, amide 10 and OEl of Glu 
14, and OEl of Gin 10 and amide 267. Electron density representative of the quality of 
the P2i and P2i2i2i crystal structures appears in Figure 3.3. 
In spite of differences in the conditions of crystallization and lattice contacts (see 
below), sites for water molecules associated with each of the four crystallographically 
independent polypeptide chains show a significant level of agreement. Superposition of 
the solvent structures, using the transformations that bring-about the superposition of 
the polypeptide chains themselves, reveals that 55% of water sites correspond to at least 
one other site of another polypeptide chain with an overall root-mean-square deviation 
of 0.72 A. 
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Figure 3.2 Distribution of <j), ij) angles for amino acid residues of the P2i 
crystal form (top) and the P2i2i2i crystal form. Letter o resp-
resents glycine and x all other residue types. Significant outliers 
are labeled. 
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Figure 3.3 Stereoview of (2Fo6s-Fca/c)exp(iaca/c) electron density of the 
P-loop of the P2i crystal form. The contour level is 6-a using a 
cover radius of 1.0 A. 
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3.4.2 Secondary structure and fold 
The secondary structure of the synthetase is presented in Figures 3.4 & 3.5 and 
Tables 3.2 & 3.3. The assignment of 3/10-helices differs from that of Poland et al. 
[81] in two respects. The structural element linking /3-strand B2 to B3 has a single 
turn of 3/10-helix, labeled Hi' in Table 3.2. Similarly the polypeptide between /3-strand 
BIO and Bll has a single turn of 3/10-helix, labeled HIO'. As in Poland et ai [81], 
residues classified as a- or 3/10-helical belong to a run of 4 or more residues which have 
(j),'il) angles within ±30° of the typical values for a- or 3/lO-helices. Those residues at 
the ends of helices, which deviate by more than 30° from typical <j> and t]} values, were 
included as part of the helix, provided that they participated in the hydrogen bonding 
of the helix. Approximately 41% of all residues belong to helices. 
The assignment of /3-strands differs from Poland et al. [81] by the addition of a loop 
consisting of two strands B2a and B2b (residues 39-53). The positions of a-carbons in 
this antiparallel loop do not differ significantly from those of Poland et al., especially 
in view of the high thermal parameters (15 to 45 in the P2i2i2i crystal form, for 
instance) present here. Instead, the assignment of a regular secondary structure to 
residues 39-53 in the refined models, is a consequence of a higher level of confidence in 
the assignment of inter-strand hydrogen bonds. In general, each residue of designated 
jS-strands participates in at least one hydrogen bond with a neighboring strand. Each (3-
strand of sheet structures makes at least two hydrogen bonds with neighboring strands. 
Approximately 21% of all residues of the synthetase belong to sheet structures. 
By the criteria of Lewis et al. [93], the synthetase has 31 reverse turns, involving 
approximately 29% of the entire structure. The Type I turn is most prevalent, occuring 
in 22 out of 31 instances. At best only 40% of the turns have hydrogen bonds between 
carbonyl i and amide i-t-3, which is slightly lower than the average (50%) observed for 
other proteins [94] [95] [92]. No disulfide linkages are present in the synthetase. The 
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Figure 3.4 Revised topology diagram for adenylosuccinate synthetase. Cir­
cles represent a-helices, and squares represent (3- strands. New 
elements of secondary structure are shown in dashed lines. Sin­
gle loops of 3/10-helices are not shown. 
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Figure 3.5 Stereo ribbon drawing of one monomer of the synthetase dimer. 
In order to better reveal the central ;3-sheet of the synthetase, 
strands B2a and B2b of Table 3.2 are represented as a loop. 
Drawing by MOLSCRIPT." 
°Reference[91] 
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Table 3.2 Correspondence of secondary structure to the sequence. 
Type and name Sequence spanned 
of element by the element 
/3-Strand B1 2-7 
a-Helix HI 16-26 
/9-Strand B2 28-32 
/3-Strand B2a 39-45 
/3-Strand B2b 48-53 
3/10-Helix Hi' 57-60 
/3-Strand B3 65-69 
a-Helix H2 76-88 
3/10-Helix H2' 92-96 
Strand B4 97-99 
a-Helix H3 108-120 
a-Helix H4 133-142 
3/10-Helix H5' 148-152 
a-Helix H5 154-176 
a-Helix H6 183-199 
/3-Strand B5 200-202 
a-Helix H7 204-213 
/3-Strand B6 217-222 
a-Helix H8 245-252 
/3-Strand B7 261-268 
/3-Strand B8 270-272 
a-Helix H9 285-293 
^-Strand B9 306-308 
a-Helix HIO 312-322 
/3-Strand BIO 325-330 
3/10-Helix HIO' 332-335 
/3-Strand Bll 337-349 
/3-Strand B12 354-355 
/3-Strand B13 369-378 
a-Helix Hll 393-406 
j0-Strand B14 411-413 
j3-Strand B15 423-425 
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Table 3.3 Reverse turns of adenylosuccinate synthetase". 
i Distance (A) Residues (degrees) (degrees) Turn 
O.-Ni+a" Z-j-l,ZT2 i+l^ i+2^ type"^ 
1 4.90 Asn, Asn -68, -42 -102, 106 vni 
27 6.78 Lys, Tyr -98, -32 -128, 139 VIII 
45"^ 3.09 Asn, Gly 51, 63 60, 21 I' 
52 6.88 His, Leu -106,-26 -120,-51 p 
61 3.57 Glu, Asn -62, -48 -90, 20 I 
69 3.15 Asn, Gly -60, -23 -70, -19 I 
100 3.55 Glu, Ala -73, -11 -93, 0 I 
225 3.21 Thr, Leu -56, -47 -71, 3 I 
226 3.04 Leu, Leu -71, 3 -103, 3 I 
229 3.62 lie, Asp -53, -40 -88, -48 p 
230 4.90 Asp, His -88, -48 -105, 11 I 
234 2.80 Tyr, Pro -59, 140 -89, 7 via 
235 6.44 Pro, Tyr -89, 7 -85, 69 _/ 
255 3.07 Pro, Arg -51, -41 -72, -7 I 
256 3.66 Arg, Tyr -72, -7 -93, 10 I 
267 5.13 Ala, Tyr -56, -20 -142, 174 VHP 
278 3.12 Pro, Thr -56, -15 -108, 12 I 
335 3.46 Asp, Gly -63, 139 92, -9 II 
338 5.87 Lys, Glu -79, -36 -134, 144 VIII 
349 2.92 Pro, Asp -59,-10 -110, 19 I 
360^ 3.40 Ala, Ala -65, -29 -80, 0 I 
364 3.32 Trp, Lys -73, -21 -74, -28 I 
365 3.97 Lys, Gly -74, -28 -95,-12 I 
382 3.47 Phe, Gly -67, 123 86, -4 II 
387 3.22 Arg, Ser -61, -33 -62, -36 I 
388 3.08 Ser, Gly -62, -36 -79, 12 I 
418 2.99 Arg, Thr -55,-37 -74,-17 I 
419 4.01 Thr, Glu -74,-17 -89, 64 p 
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Table 3.3 (Continued) 
i Distance (A) Residues (degrees) ^,•0 (degrees) Turn 
O.-N.+3' i-\-1, i-t-2 t-1-1' i+2'' type'' 
424 4.46 Leu,Arg -83,-22 -137, -31 P 
427 3.10 Pro, Phe -52, -36 -74, -21 I 
428 3.63 Phe, Asp -74, -21 -93,-29 I 
"Residues i to t+3 belong to a reverse turn if the distance CA,- to CA,+3 is less than 7.0 A and 
if residues j+1 and j+2 do not belong to an a-helix. 
''Values here are averages of the four crystallographically independent polypeptide chains from 
the P2i2i2i and P2i crystal forms. 
® Listed angles for residues j+1 and i+2 are usually within ±30° of ideal angles for the corre­
sponding type of turn with perhaps one of the <j),ip angles deviating by as much as ±45°. Ideal 
values are from Wilmont Si Thornton [92]. 
"'Average of values from only the P2i2i2i crystal form. 
®One or more of the angles deviate by more than ±45" from the ideal values used by Wilmot 
& Thornton [92]. 
^Turn involves a cis-peptide linkage. No classification was made. 
^Average of values from only the P2i crystal form. 
peptide linliage between Tyr 235 and Pro 236 remains in a cis conformation, as reported 
previously [81]. 
The polypeptide fold reported by Poland et al. [81] is unchanged, aside from the 
assignment of new secondary structure (Table 3.2). The polypeptide chain folds into a (3-
sheet of 9 parallel strands with a 10"* strand antiparallel to the previous nine (Figure 3.4). 
Elements of structure which connect ;S-strands B2 to B3, B4 to B5, B7 to BIO and BIO 
to B14 are subdomains of the central /3-sheet. Loops from each of these subdomains 
comprise the putative active site of the enzyme. Some of these loops undergo significant 
conformational change in response to analogs of IMP and GTP (see below). Only 9% of 
the residues (approximately 39 residues) of the the synthetase do not belong to helical, 
/S-strand, or turn structures. Perhaps as many as 15 of these "random coil" residues 
belong to loop elements, which comprise the putative active site. 
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Figure 3.6 (Top) Stereoview of the trace of the synthetase dimer as 
viewed down its twofold symmetry axis. In bold are elements 
which comprise the interface between the helical subdomains 
of the dimer. (Bottom) The relationship of helices H4 to each 
other and to the loops 121-130, which are repesented in boldface. 
The 5'-phosphate of IMP interacts with Arg 143 and residues of 
the loop 121-130. Illustrations, top and bottom, have identical 
orientations of the synthetase. ® 
''Refetence[44] 
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Table 3.4 Lattice contacts pf the P2i crystal form". 
First residue Bridging Water*" Second residue 
Interface no. 
Glu A25 OEl Asp B387 ODl 
Arg A26 NH2 Wat A795 Arg D419 NHl 
Wat A795 Arg D419 NH2 
Lys A28 NZ Asp B430 0D2 
Glu A62 OEl Arg B388 NHl 
Arg B388 NH2 
Asn A63 ODl Wat A555 Arg B426 NE 
Wat A555 Arg B426 NHl 
Asn A63 ND2 Leu B425 0 
Arg A214 NH2 Wat A695 Asp B430 0 
Arg A214 0 Arg B26 NH2 
Arg A214 NH2 Phe B429 0 
Asp A216 ODl Arg D419 NH2 
Arg 061 NHl Asp B387 ODl 
Interface no. 2'^ 
Glu A48 0E2 Tyr A237 OH 
His A53 NE2 Wat A823 Lys A366 0 
Thr A50 OGl Lys A366 NZ 
Lys A84 NZ Phe A283 0 
Lys A84 NZ Wat A764 Glu A288 0E2 
Glu A85 0E2 Wat A666 Lys A366 NZ 
Asp A108 0D2 Wat A563 Lys A342 NZ 
Glu A118 0E2 Wat A564 Glu A354 OEl 
Lys A119 NZ Glu A354 OEl 
Lys A119 NZ Wat A564 Glu A354 OEl 
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Table 3.4 (Continued) 
First residue Bridging Water** Second residue 
Asp A182 ODl Lys A339 NZ 
Asp A182 0B2 Lys A339 NZ 
Asp A182 ODl Wat A556 Lys A339 NZ 
Asp A189 ODl Wat A685 Asp A284 ODl 
Interface no. 3® 
Asp A153 ODl Gly B301 N 
Lys A154 N Gly B301 0 
Glu A155 0E2 Phe B297 0 
Glu A155 0E2 Arg B305 NHl 
Glu A159 OEl Wat A769 Lys B49 NZ 
Asp A188 0D2 Lys B292 NZ 
Phe B278 0 Wat B577 Lys B81 NZ 
Glu B281 OEl Lys B84 NZ 
Leu B282 0 Lys B84 NZ 
Interface no. 4^ 
Ser A379 OG Lys B339 NZ 
"Contacts listed are less than 3.2A. 
''If no bridging water is listed, then the atom of the left-hand column is in direct contact with 
the corresponding atom of the right-hand column. 
'Entries in the right-hand column come into contact with those listed in the left-hand column 
after applying the operator —a:, y — 1/2, —z to their fractional coordinates. Entries in the left-hand 
column come into contact with those listed in the right-hand column after applying the operator 
-X, y -I-1/2, —z to their fractional coordinates. 
''Entries in the right-hand column come into contcict with those listed in the left-hand column 
after applying the operator —x,i/—1/2,—z-t-l to their fractional coordinates. Entries in the left-hand 
column come into contact with those listed in the right-hand column after applying the operator 
—z, y + 1/2, —2 + 1 to their fractional coordinate.s. 
® Entries in the right-hand column come into contact with those listed in the left-hand column 
after applying the operator —x—1, j/—1/2, —z to their fractional coordinates. Entries in the left-hand 
column come into contact with those listed in the right-hand column after applying the operator 
—X — 1,2/-I-1/2, —z to their fractional coordinates. 
^ Entries in the right-hand column come into contact with those listed in the left-hand column 
after apply ing the operator x — 1,y,z — I to their fractional coordinates. Entries in the left-hand 
column come into contact with those listed in the right-hand column after applying the operator 
r -h 1, y, 2 -t-1 to their fractional coordinates. 
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3.4.3 Lattice and intersubunit contacts 
The number of lattice contacts (Tables 3.4 & 3.5 in the P2i crystal form are nearly 
twofold greater (77 contacts as opposed to 40), than for the P2i2i2i crystal form, con­
sistent with the superior resolution in the diffraction data exhibited by the P2i crystal 
form (Table 3.1. GTP and GTP analogs readily destroy the P2i crystal form, but not 
the P2i2i2i crystal form. Contacts between dimers in the P2i lattice (Interface 2 and 
3) infringe upon the putative binding site for GTP. 
The interface between monomers of the synthetase dimer is comprised entirely of 
structural elements which connect individual strands of the central /?-sheet. Intersub­
unit contacts involve two regions, which are separated from each other almost entirely. 
One interface region (hereafter, the "helical interface") comes-about through the asso­
ciation of the helical subdomains (helices H3 to H6) of each polypeptide chain (Fig­
ure 3.6). Residues 167-176 (belonging to helix H5) of each polypeptide chain self-
associates through a combination of hydrophobic and hydrophilic interactions. The side 
chains of Tyr A167, Phe A170, Tyr B175, and Tyr B176 form a loose cluster, which 
is approximately 10 A away from the cluster related by the molecular twofold axis. 
The dominant hydrogen bonding interactions involve the side chains of Gin A171, Tyr 
B167 and Tyr A176 (Table 3.6). Although the interactions between helices H5 are 
predominantly hydrophobic, the side chain packing is poor, as evidenced by significant 
infiltration of water molecules. In preparations of the synthetase, small quantities of the 
enzyme adhere tightly to the phenylsepharose column and can be removed as a single 
peak only by elution with distilled water. Such enzyme will not crystallize readily. The 
tight interaction between enzyme and phenylsepharose may involve the aforementioned 
clusters of hydrophobic residues, and lead to a partial unfolding of the synthetase or its 
dissociation into monomers. 
Residues 134-152 (principally helix H4) also contribute prominently to the helical 
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Table 3.5 Lattice contacts of the P2i2i2i crystal form.". 
First residue Bridging Water*" Second residue 
Interface no. F 
Asn A46 ODl Gly B122 0 
Lys A49 NZ Glu A159 0E2 
Lys A49 NZ Wat A587 Glu A159 0E2 
Asn A295 ND2 Wat A544 Gin A184 OEl 
Gly A299 N Glu A155 OEl 
Gly A299 N Glu A155 0E2 
Interface no. 2'^ 
Gin A210 NE2 Gly B384 0 
Arg A214 NE Phe B383 0 
Arg B348 NE Asp B430 ODl 
Arg B348 NH2 Asp B430 ODl 
Asp B351 0 Wat B545 Leu B425 0 
Glu B354 N He B424 0 
Thr B356 OGl Wat B524 Thr B420 0 
Arg B401 NHl Glu B25 OEl 
Arg B40I NH2 Glu B25 0E2 
Glu B404 0E2 Arg B61 NH2 
Glu B373 0E2 Wat 561 Asn B63 ND2 
Interface no. 3® 
Lys C366 NZ Glu B85 OEl 
Lys A366 NZ Wat B616 Glu B85 0E2 
Interface no. 4-^ 
Ala A431 OTl Asn B174 ND2 
"Contcicts listed are less than 3.2 A. 
''If no bridging water is listed, then the atom of the left-hand column is in direct contact with 
the corresponding atom of the right-hand column. 
•^Entries in the right-hand column come into contact with those listed in the left-hand column 
after applying the operator —» -t-1, j/ — 1/2, —? — 1/2 to their fractional coordinates. Entries in the 
left-hand column come into contact with those listed in the right-hand column after applying the 
operator —a: -I-1, y -f 1/2, —z — 1/2 to their fractional coordinates. 
''Entries in the right-hand column come into contact with those listed in the left-hand column 
after applying the operator x — 1/2,—y-f 1/2,—z to their fractional coordinates. Entries in the 
left-hand column come into contact with those listed in the right-hand column after applying the 
operator i -1-1/2, —?/ -|-1/2, —z to their fractional coordinates. 
® Entries in the right-hand column come into contact with those listed in the left-hand column 
after applying the operator —ar,y — 1/2,—z — 1/2 to their fractional coordinates. Entries in the 
left-hand column come into contact with those listed in the right-hand column after applying the 
operator —x, y + 1/2, —z — 1/2 to their fractional coordinates. 
^ Entries in the right-hand column come into contact with those listed in the left-hand column 
after applying the operator —x + 1/2,—y + 1, z — 1/2 to their fractional coordinates. Entries in the 
left-hand column come into contact with those listed in the right-hand column after applying the 
operator —x + 1/2, —y + 1, z + 1/2 to their fractional coordinates. 
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Figure 3.7 (Top) Stereoview of the Ca trace of the synthetase dimer as 
viewed down its twofold symmetry axis. In bold are elements 
which comprise the core interface. (Bottom) Interactions of con­
served residues participating in the core interface. Arg 143, and 
residues 239-241 belong to the binding site for the 5 -phosphate 
of IMP. Illustrations, top and bottom, have identical orienta­
tions of the synthetase, which are related to those of Figure 3.6 
by a rotation of 180° about a vertical axis. 
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interface. Unlike the interactions between helices H5, those between helices H4 are 
entirely hydrophilic. Glu A138, Arg A117 and Arg B144 form an elaborate network 
of salt-links, which are duplicated just 5 A away by molecular symmetry (Figure 3.6). 
Water infiltrates the interface, as in the case of the interface between helices H5. The 
closest point of approach of the two active sites of the synthetase dimer (see below) 
is the binding site for IMP. Thr 128 and Thr 129, conserved residues implicated in the 
binding of IMP, are immediately before the N-terminus of helix H4; Arg 143, immediately 
after the C-terminus of helix H4, approaches the IMP binding site related by molecular 
symmetry. Thus, helix H4 structurally links the IMP binding sites of the synthetase 
dimer (Figure 3.6). Studies in initial rate kinetics [13] and ligand binding [80] provide 
no evidence of cooperativity. If under conditions of low protein concentration, however, 
the monomeric form of the enzyme is present in equilibrium with the dimer, then IMP 
(and perhaps the other substrates as well) could shift the equilibrium in favor of the 
dimer. Reports of monomeric adenylosuccinate synthetase are in the literature ([5]. 
The second region of the subunit interface (hereafter, the "core interface") of the 
dimer involves residues 69-71, 100-102, 203-206, 230-258, 317-325 and 359-362 (Fig­
ure 3.7). The structural elements connecting )3-strands B6 to B7 (including helix H8) 
and /3-strands B9 to BIO (including helix HIO) dominate the core interface. The most 
significant of the contacts are hydrogen bonds between His A232 and carbonyl B250, Arg 
A257 and carbonyl B323, Arg A317 and Asp B203 and the duplicate set of interactions 
related by molecular twofold symmetry. In addition to the above, is a pair of hydrogen 
bonds between amides B361 and B362 to Glu AlOl, as well as the symmetry related 
interactions. The interactions involving Glu 101 are present in the P2i crystal form, but 
are weak or absent altogether in the P2i2i2i crystal form (Table 3.6). In fact, the data 
of Table refdimer.contacts reveals a definite reduction in the number of polar contacts 
between the subunits of the dimer in the P2i2i2i crystal form relative to the P2i crystal 
form. The decrease in polar contacts stems primarily from conformational differences in 
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the loop 360-364 of chain B of the P2i2i2i crystal form. The solvent structure under­
goes significant change in the region of Glu AlOl, and Glu AlOl itself forms a new salt 
link with Arg A147. As a consequence, the environments of Tyr B235, Asp B231, and 
Lys A140 also change with the net result being the reduction of intersubunit contacts. 
The conformational difference in loop 360-364 of chain B of the P2i2i2i crystal form, 
probably is a consequence of the conditions of crystallization and the influence of lattice 
contacts. Loop B360-B364 may be significant to the function of the enzyme, however, as 
preliminary crystal structures of the synthetase complexed with IMP and GTP analogs 
reveal a structure for the loop 360-364 similar to that of chain B of the P2i2i2i crystal 
form. 
Interactions between the subunits of the synthetase dimer would divide into two non-
overlapping sets, if it were not for the interaction of Lys 140 and Arg 147 of the helical 
domains with Asp 231 and Tyr 235 of the core interface (Figure 3.7). Specifically, Lys 
A140 makes a salt-link to Asp B231, and Arg A147 hydrogen bonds to carbonyl B231 
(in the P2i crystal form, only) and stacks against the face of Tyr B235. Interactions 
related by molecular symmetry to the above occur as well. 
A comparison of known DNA sequences of the synthetase reveals a small set of 
conserved residues that participate in the interface between monomers. Lys 140, Arg 
143, Arg 147, Asp 203, Asp 231, Tyr 235, Pro 236, Val 238, Thr 239, Ser 240 and 
Ser 241 are present in all known sequences of the synthetase. Of the above, however, 
Arg 143, Thr 239, Ser 240 and Ser 241 are near the putative site for IMP binding 
(see below); conservation of these residues may be a consequence of their importance 
in substrate recognition. Indeed, although Arg 143, Thr 239, Ser 240 and Ser 241 are 
in proximity to each other, they do not contribute significant hydrogen bonds to the 
interface (Figure 3.7). Lys 140, Arg 147, Asp 203, Asp 231 and Tyr 235, however, do 
support significant interactions between monomers of the dimer. We cannot argue for a 
direct involvement in the active site for these residues. Nonetheless, the conservation of 
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Table 3.6 Interactions between subunits of the synthetase dimer." 
Residue from Bridging Water'' Residue from 
chain A chain B 
Asn A70 ND2 Asp B231 ODl 
Glu AlOl 0E2 Ala B361 N= 
Glu AlOl OEl Ala B362 N'^ 
Ala A102 0 Wat A753(A514) Asp B231 ODl 
Arg A117 NHl Wat B564(A652) Ala B142 0 
Glu A138 0E2 Arg B144 NH2 
Glu A138 0E2 Wat (B507) Tyr B167 OH"^ 
Lys A140 NZ Asp B231 ODl 
Asp B231 0D2 
Lys A140 NZ Wat A509 Asp B231 0D2= 
Asn B242 ODF 
Arg A143 NHl Val B238 0 
Arg A143 NHl Wat B568 Pro B236 0"= 
Gly A145 0 Wat B506 Tyr B235 OH^ 
Gly A145 0 Wat A744 Tyr B235 OH"^ 
Arg A147 NH2 Wat B576 Asp B231 0'= 
Gly B233 0'= 
Arg A147 NHl Wat B652'' He B230 0" 
Asp A150 ODl Wat A744 Tyr B235 0H= 
Asp A150 0D2 Wat A744 Tyr B235 0H= 
Lys A160 NZ Wat A744 Tyr B235 0H= 
Tyr A167 OH Gin B171 OEl 
Tyr A167 OH Wat B515(A675) Arg B117 NE 
Wat B515(A675) Arg B117 NH2 
Wat B515(A675) Gin B171 OEl 
Wat B515(A675) Tyr B176 OH 
Tyr A167 OH Wat (B507) Tyr B176 OH'' 
Tyr A167 N Wat (B635) Tyr B175 OH'' 
Gin A171 OEl Tyr B167 OH 
Asp A203 ODl Arg B317 NH2 
Asp A203 ODl Wat A732(B534) Thr B358 0 
Asp A203 0D2 Arg B317 NHl 
Ser A205 OG Arg B317 NHl 
Ser A205 OG Wat B653(A662) His B232 NDl 
Asp A206 0D2 Gin B320 NE2 
Asp A206 0D2 Wat A707 Thr B357 OGP 
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Table 3.6 (Continued) 
Residue from Bridging Water" Residue from 
chain A chain B 
Asp A231 0 Arg B147 NHl" 
Asp A231 0D2 Lys B140 NZ 
Asp A231 ODl Lys B140 NZ 
Asp A231 ODl Wat A524 Ala B102 0'^ 
His A232 NE2 Thr B250 0 
His A232 NDl Wat A534 Ser B205 OG'' 
Tyr A235 OH Gly B145 0 
Tyr A235 OH Wat B661{A634) Gly B145 0 
Wat B661 Asp B150 ODl"^ 
Wat B661 Asp B150 002"^ 
Wat B661 Lys B160 NZ'^ 
Val A238 0 Arg B143 NHl 
Pro A236 0 Arg B143 NHl 
Ala A249 0 Wat A738 Leu B321 0"^ 
Thr A250 0 His B232 NE2 
Arg A257 N Ser B323 OG 
Arg A257 NH2 Ser B323 0 
Arg A317 NHl Asp B203 0D2 
Arg A317 NH2 Asp B203 ODl 
Val A319 0 Wat A758(B584) Tyr B258 OH 
Leu A321 0 Wat A629 Ala B249 0"^ 
Ser A323 OG Pro B256 N 
Arg B257 N 
Ser A323 0 Arg B257 NHl 
Leu A324 0 Wat A505 Tyr B258 OH'^ 
Ser A325 OG Arg B257 NHl"^ 
Ser A325 0 Arg B257 NHl'' 
Thr A358 0 Wat B620(B641) Asp B203 ODl 
Ala A361 N Glu BlOl OEl"^ 
Glu BlOl 0E2 
Ala A362 N Glu BlOl OEl'' 
"Waters here are for the P2i crystal form and in parentheses for the P2i2i2i crystal form. 
"Distances less than 3.3 Aare listed. Contacts involving loops 120-130 are omitted. If a contact 
is less than 3.3 Ain one crystal form, it is considered present in the other crystal form as long as the 
corresponding contact distance does not exceed 3.8 A. 
'Waters here are for the P2i crystal form and in parentheses for the P2i2i2i crystal form. 
^Observed only in the P2i crystal form. 
''Observed only in the P2i2i2icrystal form. 
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Lys 140, Arg 147, Asp 203, Asp 231 and Tyr 235 suggests an essential function, which, on 
the basis of crystal structures reported here, is the stabilization of the dimer. Mutations 
of Arg 147 to Leu [77] and Lys 140 to He [67] inactivate the synthetase. Although the 
reason for the loss of activity is unclear, one possible explanation is that the monomeric 
form of the enzyme may be inactive and that the mutation of conserved residues at 
the interface prevents the formation of the active dimer. Preliminary crystallographic 
structures of the synthetase complexed with GTP and IMP analogues, places Arg 143 
from the symmetry-related subunit at the IMP binding site, which is fully consistent with 
a dimer being required for activity. Investigations of Rudolph [96], however, indicate that 
the relationship of activity of the synthetase to its state of aggregation may be more 
complex than the association of inactive monomers to form an active dimer. Under 
certain conditions the synthetase from E. coli is apparently active in a monomeric state. 
3.4.4 Identification of the active site 
Four sources of information are available in identifying the active site of adenylosuc­
cinate synthetase: i) structural homology to proteins complexed with GTP, ii) residues 
conserved amongst synthetases from diverse sources, iii) mutation of specific residues 
leading to a loss of activity without disrupting the native fold of the polypeptide, and 
iv) preliminary crystal structures of ligand-synthetase complexes. On the basis of sim­
ilarity to the structure of the p21 ras protein [60] [97], Poland et al. [81] identified the 
putative binding site for GTP at one end of a long crevice that measures 12 A deep by 
12 A across and 30 A long. The 7-phopshate of the modeled synthetase-GTP complex is 
approximately at the midpoint of the crevice, suggesting that the remainder of the cavity 
is available to IMP and aspartate. The putative region of IMP and aspartate binding, 
therefore, is near the positions of loops 298-304 and 121-130 (Figure 3.8). As described 
below, these loops are poorly ordered in the unligated enzyme. The preliminary crystal 
structures of P2i2i2i crystals soaked in the presence of GTP analogs [44], reveal electron 
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Figure 3.8 Identification of the active site of the synthetase (top) by the 
location of IMP and GDP in a preliminary crystal structure, 
(middle) by directed mutation, and (bottom) by the mapping 
of conserved residues of synthetases from bacteria, yeast and 
mammals. Drawing by MOLSCRIPT.® 
"Referencepl] 
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density for guanine nucleotides in the crevice consistent with the modeling studies of 
Poland et al. [81]. In addition, preliminary structures of crystals grown in the presence 
of GTP and IMP analogs [44], indicate density for analogs of IMP at the end of the 
crevice opposite to that occupied by guanine nucleotides (Figure 3.8). 
Studies in directed mutation, taking into account the results of kinetic analyses, 
brings-about a mapping of functionally important residues onto the stucture, which 
is entirely consistent with the placement of ligands in the active site on the basis of 
preliminary crystallographic and modeling studies (Figure 3.8). Mutations He 19 to 
Thr, Lys 331 to Leu and Asp 333 to Asn have significant effects on the Km of GTP, but 
only modest effects on the Km for IMP and aspartate [54] [56] [57]. Positions 331 and 333 
are implicated in the direct interaction with the base of GTP (see below), whereas, the 
influence of position 19 on the binding of GTP must be indirect through a conformational 
change in the mutant protein. Aspartate binding (K^) is sensitive to mutations at Arg 
303, 304 and 305 [59]. The arginine residues belong to one of the disordered loops of 
the synthetase (see below) and adopt positions which fall between the putative sites for 
GTP and IMP binding. In addition, the mutations Gly 12 to Val, Gly 15 to Val, Gly 
17 to Val, Lys 18 to Arg, He 19 to Thr, Arg 305 to Leu, and Asp 333 to Asn also have 
significant effects on kcot, implying a role for these residues in organizing the active site 
into a catalytically competent state. Gly 12, 15 and 17 belong to the P-loop ([53]) of 
the synthetase ([54]; [81]); these residues are near the putative binding sites for the a-
and /3-phosphates of GTP. Interestingly, the mutations at positions 12,15 and 17 do not 
influence the Km of GTP ([54]). One explanation of this phenomenon is that the binding 
energy of the phosphate moiety of GTP drives a conformational change in the active site 
(and hence the effect on kcat), but does not enhance the affinity of GTP for the enzyme. 
Instead, the affinity of GTP for the active site may be determined by interactions at the 
base, as is consistent with published K,- for GDP being approximately equal to the K^ 
of GTP [13]. 
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The identification of the crevice as the active site of the synthetase is consistent 
with the mapping of residues conserved amongst the known sequences of adenylosucci­
nate synthetase. The conserved residues generally fall into the core (solvent inaccessible 
regions) of the synthetase dimer (Figure 3.8), but also involve residues of the poorly 
ordered loops 121-130 (specifically, Gly 127, Thr 128, and Thr 129) and 298-304 (specif­
ically, Thr 300, Thr 301, Gly 302, and Arg 303). Conserved residues, outside of the 
aforementioned loops, but still an integral part of the crevice, include Gly 8, residues 
10-18, Asp 21, residues 35-36, residues 38-42, His 53, residues 56-58, Asp 114, Glu 118, 
residues 132-135, Arg 143, residues 221-223, residues 239-241, Gly 274, Gly 276, and 
Asp 333. The low level of conservation of surface residues exhibited by the family of 
adenylosuccinate synthetcises may be a manifestation of the different isoelectric points of 
the enzyme associated with muscle (pi approximately 9), as opposed to the nonmuscle 
enzyme (pi approximately 6). Variations in surface residues may also reflect differences 
in protein-protein or protein-nucleic acid interactions of the synthetase family. 
3.4.5 Relation of the synthetase to consensus sequences 
Four consensus sequences are putatively common to all GTP-binding proteins: i) 
an N-terminal phosphate binding loop (P-loop or Gl-region) of sequence GXXXXGK, 
ii) a Mg^"*" binding sequence (G2-region) DX„T, iii) a central phosphate binding se­
quence (G3-region) (D/E)XX(G/A) and iv) a guanine recognition sequence (G4-region) 
(N/T)KXD [47] [98]. The P-loops of all synthetases, for which sequence information is 
available, differs significantly from the consensus sequence GXXXXGK. Superposition of 
the P-loop from AMPsase (residues 4 to 23) onto that of the p21 ras protein (Figure 3.9) 
reveals that Thr 9, Gin 10, and Trp 11 are used in place of a single residue between the 
essential G and GK-pair of the consensus sequence. Thus, the synthetase P-loop corre­
sponds to the sequence GXXXXXXGK. The P-loop of dethiobiotin synthetase from E. 
coli, an ATP hydrolyzing enzyme with a polypeptide fold similar to that of adenylosucci-
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Figure 3.9 Superposition of the P-loop of p21 ras onto the synthetase. The 
P-loop of the p21 ras protein is represented as a trace of its 
a-carbons, using bold lines, whereas all atoms of the correspond­
ing loop of the synthetase are shown. 
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nate synthetase, also diverges from the consensus sequence, having five residues between 
the essential G and GK-pair [85]. The extended size of the P-ioop in adenylosuccinate 
synthetase, relative to that of the p21 ras protein may be directly related to differences 
in the roles that GTP plays in the chemical transformations governed by these proteins. 
The p21 ras proteins hydrolyze GTP in order to drive a conformational change, whereas 
the synthetase putatively transfers the 7-phosphate of GTP to IMP. 
A second feature of the P-loop of adenylosuccinate synthetase is the presence of two 
conserved acid side chains (Asp 13 and Glu 14) in a region putatively responsible for 
the binding and hydrolysis of GTP. The side chain of Glu 14 "threads" the "eye" of the 
P-loop, hydrogen bonding to the backbone amides of residues 10 and 12 (Figure 3.9). 
The increased size of the P-loop in the synthetase may require the presence of Glu 14, 
in order to maintain a stable conformation. Indeed, the "add-on" residues (particularly 
Thr 9 and Gin 10) also stablize the P-loop of the synthetase by participating in as many 
as six hydrogen bonds. The role of Asp 13, however, is not yet entirely clear. Model 
building studies of Poland et al. [81] and preliminary structures of guanine nucleotide 
complexes bring the 7-phosphate of GTP into the vicinity of Asp 13. An Asp 13 to 
7-phosphate interaction is unlikely at pH 7. Nonetheless, the mutation of Asp 13 to Ala 
eliminates catalytic activity [90]. A possible role for Asp 13 in the binding of Mg^""" is 
discussed below. 
The G4-region (guanine recognition element) is present in the synthetase at one loca­
tion (residues 330 to 333). Mutation of Lys 331 to Leu or Arg reduces the Km for GTP, 
but leaves k^ai unchanged [56] and the mutation of Asp 333 to asparagine transforms 
the synthetase from a GTP hydrolase to an even more profBcient XTP hydrolase [57]. 
Model building by Poland et al. [81] indicates the guanine recoginiton element of the 
synthetase interacts with GTP similarly to that of the p21 ras protein. In the model, 
Lys 331 packs against the face of the base, and Asp 331 hydrogen bonds to the exocyclic 
2-amino and endocyclic N1 position of guanine. 
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Figure 3.10 Stereoview of the superposition of four independent polypep­
tide chains of the unligated synthetase. Drawing by 
MOLSCRIPT." 
''Reference[91] 
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The consensus sequences for region G2 and G3 axe not reliable indications of function 
in the E. coli synthetase. The consensus sequences (D/E)X„(G/T) (02 region, central 
phosphate binding) and (D/E)XX(G/A) (G3 region, binding) appear at least 
10 times in the synthetase from E. coli. A G2 region assigned to residues 260-268 of 
mouse non-muscle adenylosuccinate synthetase [84], corresponds to residues 231-239 of 
the E. coli enzyme. Although Thr 239 is part of the putative active site, its location 
corresponds to the binding site for IMP (Figure /refactive.site). The G3 region assigned 
to residues 292-295 of the mouse nonmuscle enzyme corresponds to 261-264 of the E. 
coli synthetase, a region far-removed from the active site crevice. 
On the basis of structural homology to p21 ras proteins [60] [97] and G^ proteins 
[99], Mg^+ should bind in the vicinity of the side-chains of Glu 221 and Ser 57 of the 
E. coli synthetase. Sufficient space exists in this region to accommodate a Mg^"^ and 
permit the coordination of that Mg^"*" to GTP. In the unligated structures reported here, 
Lys 16 interacts with Glu 221 (see below), and in preliminary structures of complexes 
of GTP and IMP analogs, His 41 is in the vicinity of Glu 221, displacing Lys 16 from its 
position in the unligated structures. We find no indication of Mg^"*" in the vicinity of Glu 
221. In addition, a Thr/Ser residue after the GK-pair in the P-loops of p21 ras and Gq 
proteins is involved in the coordination of Mg^"*", but in all members of the synthetase 
family the equivalent position (17 in the E. coli enzyme) is occupied by glycine. Thus, 
apparently adenylosuccinate synthetase interacts with Mg^"^ through structural elements 
entirely different from those of the p21 ras and Gq proteins. Assuming that Mg^"*" binds 
to the 13- and 7-phosphates of GTP, Asp 13 of the P-loop becomes the most likely site 
of recognition for Mg^"*", hence addressing the issue of a conserved, negatively charged, 
and catalyticaly essential residue in proximity to the phosphates of GTP analogs. 
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3.4.6 Relationship of structural disorder to the active site 
The combined asymmetric units of the P2i and P2i2i2i crystal forms provide four 
crystallographically independent copies of the polypeptide chain of adenylosuccinate 
synthetase. Superposition of the models for each polypeptide chain should reveal el­
ements of ambiguous structure and/or differences in structure. The superposition of 
four polypeptide chains appears in Figure 3.10 along with a measure of the root-mean-
square deviation in the atomic positions as a function of residue number (Figure 3.11). 
Approximately 90% of the four polypeptide chains (excluding elements 42-50, 121-131, 
298-304, and 360-364) give a root-means-square deviation in atomic positions of main 
chain atoms of 0.31 A. Thus, no significant violation of the twofold molecular symmetry 
axis is apparent for a sizable fraction of the dimer. 
The loop elements, named above, deviate to a greater extent than the overall uncer­
tainty in atomic positions. A plot of average thermal parameter against residue number 
(Figure 3.11) reveals that the four loop elements exhibit substantial thermal param­
eters as well. Thus, the large root-mean-square deviations in atomic position for the 
loop elements are due at least in part to uncertainties in structure which arise from 
the inherent flexibility of the polypeptide chain. As discussed below, however, the loop 
structures do exhibit real conformational differences, probably in response to different 
packing environments within the two crystal forms. 
Models for the loop element 42-50 are associated with moderate electron density in 
the P2i2i2i crystal form and weak density in the P2i crystal form. The relative positions 
of the loops are approximately the same for each of the four polypeptide chains. However, 
chains A and B of the P2i crystal form show disconnected density for the loop 42-50 
in an alternate position. This alternate position (not part of the model) corresponds to 
the location of this loop in crystals of the synthetase complexed with IMP and GTP 
analogs [44]. 
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Figure 3.11 (Top) Plot of the root-mean-squared deviation in the position 
of main chain atoms as a function of residue number for the four 
independent polypeptide chains after superposition. (Bottom) 
Plot of the average thermal parameter for main chain atoms as 
a function of residue number for chain B of the P2i2i2i crystal 
form. 
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The loop element 360-364 is identical for chains A and B of the P2i crystal form and 
is associated with good to excellent electron density. The same region in the P2i2i2i 
crystal form has generally weak to moderate electron density. In fact, in the P2i2i2i 
crystal form element 360-364 of chain B is in a conformation that differs significantly 
from that of the P2i crystal form. The conformation of loop B360-B364 of the P2i2i2i 
crystal form is essentially the same as that observed in complexes of the synthetase with 
IMP and GTP analogs. 
The loop elements 121-131 and 298-304 are in poor electron density; the model here 
is reliable only as a trace of the strongest electron density. The location of the loops 
121-130 and 298-304 in the synthetase complexed with active site ligands falls within 3 
A of the corresponding loop of the ligand-free structures. Evidence to date suggests that 
the loops 42-50, 121-131, 298-304, and 360-364 are dynamic structures, which undergo a 
significant transition to ordered structures and/or significant conformational change in 
response to active site ligands. 
In addition to the loops, several residues of each polypeptide chain appear in two 
conformations. Of these, disorder in the side chain of Lys 16 may be the most significant 
in terms of function. Lys 16 of the synthetase is the structural analog of Lys 16 of the 
p21 ras protein [81]. In the p21 ras protein Lys 16 putatively binds to the 7-phosphate 
of GTP. Presumably, Lys 16 of the synthetase has the same function. In the absence of 
GTP, however, Lys 16 of the synthetase adopts two conformations, one of which involves 
a hydrogen bond to Glu 221 and the second involves hydrogen bonds to carbonyls 39 
and 223. The alternative positions for Lys 16 may reflect the state of protonation of His 
41, which is near the side chain of Glu 221. If His 41 is neutral, then Lys 16 may favor an 
interaction with Glu 221. If His 41 is protonated, then Lys 16 may favor a hydrogen bond 
to carbonyls 39 and 223. Preliminary crystal structures of the synthetase in complexes 
of GTP and IMP analogs reveals significant conformational change with respect to the 
positions of His 41, Lys 16 and carbonyl 223. Lys 16 in ligand complexes is near carbonyl 
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39, suggesting that Lys 16 is predisposed to conformational change even in the absence 
of active site ligands. 
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4 REFINED CRYSTAL STRUCTURES OF GUANINE 
NUCLEOTIDE COMPLEXES OF ADENYLOSUCCINATE 
SYNTHETASE FROM ESCHERICHIA COLI 
A paper published in the Journal of Biological Chemistry ^ 
Bradley W. Poland, Zenglin Hou, Christina Bruns, Herbert J. Fromm and Richard B. 
Honzatko 
4.1 Abstract 
Structures of adenylosuccinate synthetase from Escherichia coli, complexed with 
guanosine-5'-(/3,7-imido)triphosphate and guanosine-5'-(j0,7-methylene)triphosphate in 
the presence and absence of Mg^"*", have been refined to R-factors below 0.2 against 
data to a nominal resolution of 2.7 A. Asp^^^ of the synthetase hydrogen bonds to the 
exocyclic 2-amino and endocyclic N1 groups of the guanine nucleotide base, whereas 
the hydroxyl of Ser'^^'* and the backbone amide of Lys®^^ hydrogen bond to the 6-oxo 
position. The side chains of Lys^^^ and Pro^^'^ pack against opposite faces of the guanine 
nucleotide base. The synthetase recognizes neither the N7 position of guanine nucleotides 
nor the ribose group. Electron density for the guanine-5'-(/3,7-imido)triphosphate com­
plex is consistent with a mixture of the triphosphate nucleoside and its hydrolyzed 
diphosphate nucleoside bound to the active site. The base, ribose and a-phosphate 
^Reprinted with permission of J. Biol. Chew... 
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positions overlap, but the /3-phosphates occupy different binding sites. The binding 
of guanosine-5'-{y3,7-methylene)triphosphate to the active site is comparable to that of 
guanosine-5'-(/3,7-imido)triphosphate. No electron density, however, for the correspond­
ing diphosphate nucleoside is observed. In addition, electron density for bound Mg^""" 
is absent in these nucleotide complexes. The guanine nucleotide complexes of the syn­
thetase are compared to complexes of other GTP-binding proteins and to a preliminary 
structure of the complex of GDP, IMP, Mg^"*", and succinate with the synthetase. The 
enzyme, under conditions reported here, does not undergo a conformational change in 
response to the binding of guanine nucleotides, and that minimally IMP and/or Mg^"*" 
must be present, in order to facilitate the complete recognition of the guanine nucleotide 
by the synthetase. 
4.2 Introduction 
Adenylosuccinate synthetase (IMP:L-aspartate ligase (GDP-forming), EC 6.3.4.4) 
catalyzes the formation of adenylosuccinate from GTP, IMP, and aspartate in the pres­
ence of Mg^""": 
GTP -1- IMP -|- L-aspartate # GDP -|- P,- -t- adenylosuccinate 
According to the proposed mechanism of Lieberman [2], the 7-phosphate of GTP is 
transferred to the 6-oxygen of IMP, whereafter the amino group of aspartate displaces 
phosphate from the 6-phosphoryl-IMP intermediate. Studies in kinetics support the 
Lieberman mechanism [41] [42] [43] [61], but alternative reaction mechanisms are in the 
literature [16] [40], The synthetase from various sources, including Escherichia coli, is 
subject to feedback inhibition by AMP, adenylosuccinate, GDP, and GMP [14] [13] [16] 
[19] [21]. Literature regarding the synthetase is reviewed by Stayton et al. [5]. 
The synthetase from E. coli is a dimer of identical polypeptide chains of 431 amino 
acids with Mr=48,000 [46] [81]. Synthetases from different sources [46] [62] [63] [64] 
[65] [82] [83] [84] show at least 40% overall identity in amino acid sequence. The syn­
thetase family has the consensus sequences commonly associated with GTP binding in 
the GTPase superfamily [47] [63] [84]. Furthermore, adenylosuccinate synthetase adopts 
a polypeptide fold similar to that of dethiobiotin synthetase from E. coli, an enzyme 
that couples the hydroylsis of ATP in the conversion of 7,8-diaminopelargonic acid to 
dethiobiotin [85] [100]. Adenylosuccinate synthetase from yeast [11] binds to T-rich, 
single-stranded DNA. However, the physiological consequences of the observed in vitro 
binding of the synthetase to DNA remain unclear. 
Crystal structures of the unligated synthetase (P2i and P2i2i2i crystal forms) are 
in the literature [81] [101]. The P2i crystal form is disordered by the gradual infusion 
of Mg^"'"-GTP and Mg^^-CDP. Most likely guanine nucleotides promote specific con­
formational changes in residues involved in lattice contacts in the P2i crystal form. In 
contrast, the P2i2i2i crystal form accepts guanine nucleotides up to concentrations of 
0.8 mM (approximately five-fold in excess of the reported Km for GTP) without the loss 
of resolution in the diffraction of X-rays. 
The current study presents crystal structures of GTP analogs (GppNp^ and GppCp) 
complexed with adenylosuccinate synthetcise. The structures reveal for the first time 
key interactions between the base of guanine nucleotides and the enzyme. In spite of the 
presence of succinate in the buffers of each of the complexes, we find no evidence for the 
ordered binding of succinate. In comparison to preliminary structures of the synthetase 
complexed with IMP, GDP, Mg^"^ and succinate (unpublished results), the base of the 
guanine nucleotide in structures reported here is recognized by the enzyme, but the 
polyphosphate moiety is not. The complexes do not lead to conformational changes 
that occur in the enzyme when IMP, Mg^"*" and succinate are present along with the 
guanine nucleotide, thus suggesting that other ligands (minimally Mg^"*" and/or IMP) 
are necessary for complete recognition of the guanine nucleotide by the synthetase. 
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4.3 Materials and Methods 
4.3.1 Preparation of enzyme. 
Adenylosuccinate synthetase was prepared from a genetically engineered strain of E. 
coli according to published isolation procedures [12] [81] [101]. The protein migrates 
as a single band on SDS-polyacrylamide gel electrophoresis with an apparent relative 
molecular weight of 48,000 (data not shown). 
4.3.2 Growth of crystals. 
Conditions for the growth of the P2i2i2i crystal form were discovered by use of the 
sparse matrix of Jancarik and Kim [86] and the method of hanging drops. Droplets 
contained 2 /xl of enzyme solution (20 mg/ml in protein), dialyzed against a solution 
(pH 7.0) consisting of imidazole (20 mM), succinate (75 mM) and 2-mercaptoethanol (70 
fA/\), and 3 /xl of a crystallization buffer, which contained 25% (w/w) polyethylene glycol 
3350, 100 mM acetic-acid/sodium acetate, pH 5.2, and 200 mM ammonium acetate. The 
final pH of the crystallization buffer was 6.5. Wells contained 500 ^1 of the crystallization 
buffer. Crystals of approximately 0.5 mm in all dimensions and belonging to the space 
group P2i2i2i (unit cell parameters a=73.42, b=93.63, c=l 19.47) grew in about one 
week. The asymmetric unit consists of an entire dimer. 
4.3.3 Preparation of ligand complexes. 
Guanine nucleotides GppNp and GppCp came from Sigma. The samples were 
checked for purity by thin layer chromatography, using polyethyleneimine plates and 
1.6 M LiCl as the eluent [102]. Guanine nucleotide complexes of the synthetase were 
formed by soaking crystals in a solution comprised of two-parts imidazole (20 mM), 
succinate (75 mM) and 2-mercaptoethanol (70 ^1/1), pH 7.0, and three-parts polyeth-
lene glycol 3350 (28%, w/w), acetic-acid/sodium acetate (100 mM, pH 5.2), ammonium 
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Table 4.1 Refinement statistics for adenylosuccinate synthetase. The GppN 
complex results from a soak of (10 mM) and GppNp (0.8 
mM), the GppN/GppNp complex results from a soak of GppNp 
(0.8 mM) and the GppCp complex results from a soak of GppCp 
(0.8 mM). 
GppN 
Complex 
GppN/GppNp GppCp 
Resolution limit (A) 2.3 2.3 2.3 
Number of measurements 106944 112059 78880 
Number of unique Refl. 36689 36474 37785 
Completeness of data set (%) 94 97 93 
Completeness of data in 
the last resolution shell (%) 84 89 85 
R a 
^sym 8.9 8.1 8.2 
Number of refl. in refinement'' 26828 29591 28364 
Number of atoms'^ 9338 9442 9261 
Number of solvent sites 386 406 345 
R-Factors"^ 
Rioo% 0.186 0.185 0.190 
R90% 0.182 0.183 0.185 
R/ree 0.230 0.210 0.227 
Resolution (A) 5 to 2.3 5 to 2.3 5 to 2.3 
Mean B (A^) for protein 
chain A 23.66 29.83 32.65 
chain B 19.09 26.46 26.21 
Rms deviations 
bond lenghts (A) 0.015 0.011 0.013 
bond angles (deg) 1.93 1.70 1.95 
dihedral angles (deg) 24.9 24.1 24.5 
improper dihedral angles (deg) 1.77 1.50 1.72 
Si I ^1 / I2i I^j lij, where i runs over multiple observations of the same 
intensity, and j runs over all crystallographically unique intensities. 
''All data in the resolution ranges indicated. 
•^Includes hydrogens linked to polar atoms. 
'^Rf actor = II ^0^' I ~ I ^calc II I ^obs ii I Pobs |> 0. 
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acetate (200 mM), and guanine nucleotide (0.8 mM), with or without Mg^"^ (10 mM). 
Crystals were exposed to the nucleotides for 48 hours prior to mounting and data col­
lection. Data from the guanine-nucleotide complexes were collected on a Siemens area 
detector at Iowa State University and were reduced by using XENGEN [87]. The data 
sets were above 90% complete to resolutions of 2.3 A (Table 4.1). The nominal resolution 
of the data sets (the resolution at which (I)=2o-(I)) is 2.7 A. 
4.3.4 Thin layer chromatography. 
The degradation of nucleotides under conditions similar to those of the ligand soaks 
was monitored on polyethyleneimine plates, using a 1.6 M LiCl solution as an eluent. 
Each of four solutions contained acetic acid/acetate (pH 5.2), ammonium acetate and 
imidazole/succinate (pH 7.0) at concentrations equivalent to those used in crystal soaks, 
along with nucleotide at 15 mM. The four solutions contained either 1) enzyme (20 
mg/ml) alone, 2) Mg^"*" (37.5 mM) alone, 3) the combination of enzyme and Mg^^ or 
4) no enzyme and no Mg^"^. At intervals of 2, 24 and 72 hours, aliquots of 5 /il were 
applied to polyethyleneimine plates, developed in 1.6 M LiCl, and visually inspected for 
UV-absorbing components. 
4.3.5 Crystallographic refinement. 
The structure of the P2i2i2i crystal form was determined by molecular replacement 
[101] using the preliminary structure of the P2i crystal form [81]. The unligated P2i2i2i 
crystal form served as the starting model for the interpretation of guanine nucleotide 
complexes. The refinement of models for ligand complexes of the P2i2i2i crystal form 
involved manual fitting of the model to the electron density, using a Silicon Graphics 
4D-25 and the program TOM [73], followed by a cycle of refinement using XPLOR on a 
Silicon Graphics 4D-35. Constants of force and geometry for the protein came from Engh 
& Huber [89]. In the refinement process, the systems were heated to 1000 or 1500°K and 
90 
then cooled in steps of 10°K. After the slow-cooling protocol Wcis completed (at 300°K), 
the models were subjected to 120 steps of conjugate gradient minimization, followed by 
20 steps of individual B-parameter refinement. Individual B-parameters were subject 
to the following restraints: nearest neighbor, main chain atoms, 1.5 A^; next-to-nearest 
neighbor, main chain atoms, 2.0 A^; nearest neighbor, side chain atoms, 2.0 A^; and 
next-to-nearest neighbor, side chain atoms, 2.5 A^. 
Water molecules were added if (i) electron density at a level of 2.5cr was present in 
maps based on Fourier coefficients (jFobsl — lFcaicl)e'""''= and (2|Fobs| — lFcaic|)e'°"'S and 
(ii) acceptable hydrogen bonds could be made to an existing atom of the model. If after 
refinement a site for a water molecule fell beyond 3.3 A from its nearest neighbor, that site 
was omitted from the model. In addition, water molecules were deleted from the model 
if their thermal parameters exceeded 80 A^. Harmonic restraints (50 kcal/mol) were 
placed on the positions of oxygen atoms of water molecules, in order to allow new water 
molecules to relax by adjustments in orientation. Occupancies of water molecules were 
not refined, because of the high correlation between occupancy and thermal parameters 
for data of a nominal resolution of 2.0-2.5 A. Thus solvent sites with B values between 
50 A^ and 80 A^ probably represent water molecules with occupancy parameters below 
1.0 and thermal parameters substantially lower than those reported from the refinement. 
4.4 Results and Discussion 
4.4.1 Quality of the refined models. 
The models for guanine nucleotide complexes of adenylosuccinate synthetase have 
been deposited in the Protein Data Bank, Brookhaven National Laboratory. The method 
of Luzzati [75] indicates an uncertainty in coordinates of 0.25 A. Segments 121-130 
and 298-304 correspond to poorly ordered loops [101], where we were able to do little 
more than indicate the course of the polypeptide chain. Refinement statistics appear in 
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Table 4.1. 
The Ramachandran plots for the guanine nucleotide complexes are unchanged (within 
experimental uncertainty) from that of the unligated P2i2i2i crystal form [101]. On the 
basis of output from PROCHECK [103], 85% of the residues belong to the most favorable 
region of the Ramachandran plot, wherecis no residue falls in the "unallowed" region. 
The overall quality of the models in terms of stereochemistry is better than the "typical" 
structure as defined by PROCHECK at a resolution of 2.3 A. 
The asymmetric unit of the P2i2i2i crystal form has a complete dimer. Thus, we 
anticipate two binding sites for guanine nucleotides, one for each of two monomers. The 
binding site associated with chain B, however, is occupied to a lesser extent than the 
binding site associated with chain A. In fact, the density for nucleotides at chain B is so 
weak in the GppNp and GppN complexes, that models for nucleotides, initially placed 
in the binding site at chain B, were deleted in the final stages of refinement due to high 
thermal parameters (approximately, 70 A^). Lattice contacts are largely responsible 
for the difference in occupancies of the guanine nucleotide binding sites of the dimer. 
The side chain of Glu^®® from a symmetry related dimer encroaches upon the nucleotide 
binding site of chain B. Furthermore, lattice contacts involving atoms of chain B are 
greater in number than those involving chain A, an observation consistent with a lower 
average thermal parameter for chain B relative to chain A (Table 4.1 ; [101]). The 
interactions, reported here, focus on nucleotides at chain A. The interactions involving 
the nucleotide at chain B in the GppCp complex are subject to high uncertainty, but 
nonetheless are similar to nucleotide-protein interactions at chain A. 
Electron density associated with GppCp at chain A appears in Figure 4.1. Although 
the electron density at a level of 3o- is continuous over the entire ligand, the thermal 
parameters of the polyphosphate moiety average to 50 A^, reflecting substantial uncer­
tainty in the atomic coordinates. Atoms of the base, however, have thermal parameters 
comparable to atoms of the surrounding protein. Under the conditions of the soak (Gp-
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02B 02B 
Figure 4.1 Stereoview of electron density associated with GppCp. The im­
age was generated from a map, based on Fourier coefficients 
(2Fo6a-Fca/c)exp[iaca/c], using a cover radius of 1.0 A and a con­
tour level of Z<T. 
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pCp, 0.8 mM), the nucleotide saturates its binding site at chain A. Nonetheless, higher 
concentrations of GppCp lead to a significant loss of resolution in the X-ray diffraction 
data, suggesting either a ligand-induced conformational change or a direct influence at 
a point of contact between protein molecules in the crystal lattice (for instance, bind­
ing to chain B). Electron density for the GppNp complex indicates an approximately 
equal mixture of GppNp and GppN (hydrolyzed GppNp) at chain A, whereas the Mg^"*"-
GppNp complex reveals moderate density for only GppN at chain A, consistent with a 
ligand occupancy of not more than 0.50. 
Thin layer chromatography of GppNp in the presence of enzyme, with or without 
Mg^"*", revealed a slow chemical transformation of the GppNp. After 24 hours in the 
presence of the enzyme, alone or with Mg^"*", GppNp appeared as an equal mixture of 
two substances, one of which corresponded to GppNp, the other to a fast-migrating sub­
stance. After 72 hours only the fast-migrating component appeared. The fast-migrating 
component had an R/ value similar to that of diphosphate nucleosides. Adenylosucci­
nate synthetase apparently catalyzes the hydrolysis of GppNp. Given our current under­
standing of the enzyme, we favor an attack by water on the 7-phosphate of GppNp, thus 
producing GppN. A complete chemical analysis of the product is necessary, however, in 
order to confirm the mechanism; the X-ray data alone are consistent with the formation 
of GppN or GDP. No degradation was observed for GppCp under identical conditions. 
Although succinate is present in all of the nucleotide complexes, electron density for 
bound succinate could not be located in difference maps. Given that initial velocity 
kinetics indicate a random equilibrium mechanism for the synthetase [13] [42], succinate 
should bind in the absence of IMP. Kang and Fromm [34] have suggested, however, 
that aspartate is recognized by the synthetase as the Mg^'^'-aspartate complex, rather 
than as free aspartate. Presumably succinate, a competitive inhibitor of the synthetase 
with respect to aspartate, is recognized by the enzyme in the form of Mg^^-succinate. 
The high acetate concentration (300 mM in total acetate) in the P2i2i2i crystal form 
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Table 4.2 Selected distances (in A) between atoms of guanine nucleotides 
and adenylosuccinate synthetase. 
Ligand Protein Distance Distance Distance 
atom atom OppN-complex OppN/OppNp-complex OppCp-complex 
N1 D333 ODl 3.64 2.90/2.89 3.17 
N2 D333 0D2 2.76 2.56/2.62 2.62 
06 S414 OG 2.87 2.81/2.83 2.68 
K331 N 3.13 2.78/2.75 3.00 
OlA K16 N 3.44 3.10/4.03 4.20 
017 N 2.93 3.13/3.41 3.66 
03A K16 N 5.86 5.64/3.14 3.72 
017 N 4.89 4.66/3.28 3.42 
OIB 017 N 3.32 3.43/3.58 5.47 
02B E14 N 9.91 9.72/3.14 4.08 
015 N 8.58 8.25/2.73 3.13 
K16 N 7.48 7.07/3.46 2.66 
T42 N 2.59 2.81/8.84 8.40 
N3B 040 0 2.83 2.61/4.51 3.51 
(or C3B) 
02G K16 NZ 10 w 4.53 
030 K16 NZ /3.69 2.81 
will reduce the pool of Mg^+ (10 mM) available to the formation of a Mg^''"-succinate 
complex. The absence of electron density corresponding to succinate in the present 
structures, then, is entirely consistent with the hypothesis of Kang and Fromm [34]. 
4.4.2 Nucleotide-synthetase interactions. 
Interactions between the base of each of the guanine nucleotides and the synthetase 
(Table 4.2; Figure 4.2) are identical to within experimental uncertainty. The synthetase 
recognizes the 6-oxo group of the base by forming hydrogen bonds to OG of Ser^^^ and 
backbone amide^^^. Ser''^'^ must function as a proton donor in its hydrogen bond to the 
6-oxo group. The hydroxyl of serine, however, can serve as a proton donor or acceptor in 
hydrogen bonds. A hydrogen bond between Lys^® and Ser"*^^ orients the dipole moment 
of the hydroxyl group of Ser"^^"* toward the 6-oxo group, thus making the hydroxyl of 
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an obligatory proton donor. Two other dipole moments, backbone amides 331 
and 416, are oriented toward the 6-oxo group, creating a local environment decidely 
in favor of a substituent with partial negative charge at position 6 of the purine ring. 
Indeed, the synthetase has a overwhelming preference for GTP over ATP as a substrate 
[2]. In addition to the 6-oxo group, Asp^^^ of the synthetase hydrogen bonds to the 
endocyclic N1 and exocyclic 2-amino group of the base (Table 4.2). The interactions of 
Asp^^ in the crystal structure are consistent with the properties of the Asn^^^ mutant, 
which no longer recognizes GTP as a substrate, presumably due to the inability of the 
NH2 group of the amide side chain of Asn^^^ to serve as a proton acceptor [57]. The 
structures reported here are also consistent with the explanation provided by Kang et 
al. [57] for the ability of the Asn^^^ mutant to recognize XTP as a substrate. The proper 
orientation of the amide side chain of the Asn^^^ mutant would result in hydrogen bonds 
to the exocyclic 2-oxo group and the endocyclic N1 of XTP. Finally, the side chains of 
Lys^^^ and Pro^^^ pack against opposite faces of the base. The interactions involving 
Lys^^^ Asp^^^, Ser^^^ and Pro^^^ were predicted by modeling studies of Poland et al. 
[81]. 
In refined complexes reported here, the nucleotides vary significantly with respect 
to the covalent structure of their phosphate moieties. We observe no electron density 
for the 7-phosphate group of GppNp or for Mg^"*" in crystals of the synthetase, exposed 
to Mg^'''-GppNp. As GppNp is susceptible to hydrolysis under the conditions reported 
here, electron density for the nucleotide in the Mg^+-GppNp soak is represented by 
GppN. In contrast, the complex of GppNp without Mg^"*" reveals moderate density close 
to the position of the 7-phosphate of GppCp. In addition, electron density for GppNp 
bifurcates at the a-phosphate, suggesting an alternate conformation for GppNp or the 
binding of a second, related guanine nucleotide. The conformation of the a- and f3-
phosphates of this "alternate conformer" is identical to that of GppN in the Mg^"""-
GppNp complex, where no density for the 7-phosphate is observed. As a consequence. 
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,Lys 33-
iLys 18 
'ro417/ 
ler414 
iSp 333 
•,02B fy® 
.Lys 33' 
lys 18 
To 417/ 
iSer414 
333 
Figure 4.2 Stereoview of GppCp (bold lines) at its site of ligation to adeny­
losuccinate synthetase. (Top) An overview representing the pro­
tein as a trace of its a-carbons. (Bottom) A detailed view of the 
region of binding of the guanine nucleotide. 
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we have interpreted the electron density in the GppNp complex in terms of the mutually 
exclusive binding of GppN and GppNp. 
Under comparable conditions GppCp and Mg^'^-GppCp give identical results; elec­
tron density is present for all three phosphates of the two GppCp complexes. No density 
is observed, however, for Mg^+ in the Mg^^-CppCp soak. In fact, we were unable to 
detect structural differences of any kind in the GppCp complexes in the presence and 
absence of Mg^+. Thus, in Table 4.1 we report only the structure for the GppCp complex 
without Mg^""". The presence of 300 mM total acetate in the crystallization buffer may be 
a significant factor in reducing the pool of Mg^"*" available to the polyphosphate moieties 
of nucleotides. The absence of Mg^"*" in the refined complexes is consistent with studies of 
Lieberman [2], which indicate the need for a relatively high concentration of Mg^"*" (1-2 
mM) for maximal activity. In the case of G.-d, Mg^"'" binds tightly to the GTP-protein 
complex (Kd of 10"^^ M; [104]), in stark contrast to the apparent dissociation constant 
for Mg^"*" from the synthetase. 
The interaction of the phosphate moieties of GppN, GppNp and GppCp with the 
synthetase differ significantly from each other (Figure 4.3, Table 4.2). For instance, 
in the GppN complex oxygen 01A of the a-phosphate binds to backbone amide^'^ and 
02B of the /3-phosphate binds to backbone amide^^. In the GppCp complex, oxygen 
02B interacts with backbone amides 15 and 16 and oxygen 03G interacts with NZ of 
Lys^®. In the case of the GppNp complex, oxygen 02B binds to backbone amides 14 and 
15, whereas oxygen 02G binds to NZ of Lys^®. The thermal parameter of atom NZ of 
Lys^® is high, suggesting that Lys^® may not reside at all times in a single, well-defined 
location, even in the presence of guanine nucleotides. 
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Gly 40 
Thr42 
Glu14  
Lys 331 Lys 18 
Ser414 
Asp 333 
Gly 40 
Thr42 
Glu14 
Lys 331 Lys i s  
5er 414 
Asp 333 
Figure 4.3 Superposition of GppN, GppNp, and GppCp in the conforma­
tions observed for these nucleotides in their ligand complexes 
with the synthetase. 
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4.4.3 Comparison of nucleotide interactions in the synthetase to those 
of other guanine nucleotide binding proteins. 
In p21'''"' [97], Gioi [105], EF-Tu [106], and the synthetase an aspartate (position 333 
of the synthetase) makes hydrogen bonds to N1 and N2 of the guanine base (Table 4.3). 
In recognition of the 06 position of guanine nucleotides, the synthetase employs a serine 
hydroxyl (Ser^^^) and a backbone amide (of Lys^^^), whereas the G,ai and p21''°® employ 
primarily a backbone amide and EF-Tu primarily a serine hydroxyl. G,ai and p21''''®, 
however, have Cys^^® and Ser^^®, respectively, each of which is close to the 6-oxo group 
of the guanine nucleotide. Furthermore, in the complexes of p21''°®, G,qi, and EF-Tu, a 
backbone amide interacts with Ser^^®, Ser^^^ and Cys^^®, respectively, to orient the dipole 
of the side chain toward the 06 position. These backbone amides apparently play a role 
which is analogous to Lys^® of the synthetase. Opposite faces of the purine base pack 
against protein side chains of Lys^^ and Pro^^^ of the synthetase, corresponding to 
similar packing interactions involving Lys"'^ and Phe^® of p21'''"', Lys^™ and Thr^^^ of 
Gfai, and Lys^^^ and Leu^'^® of EF-Tu. The most significant difference in the interaction 
of guanine nucleotides with the synthetase in relation to all other known structures of 
GTP-binding proteins is the lack of recognition of N7 of the base. In p21''°®, G,ai, 
and EF-Tu the side chain of an asparagine hydrogen bonds to position N7, whereas 
in the synthetase the closest functional group is the hydroxyl of Ser^^"^. The lack of 
recognition of N7 in the case of the synthetase may explain, in part, the large difference 
in the apparent dissociation constant of GTP from the synthetase (Km of 10~® M; [13]), 
as opposed to other GTP-binding proteins (K^ of 10~^-10~^^ M; [98]). A difference 
in the mode of recognition of Mg^+, suggested by Silva et al. [101], however, may be 
a more significant factor in the large difference in affintiy of guanine nucleotides to 
the synthetase relative to G-proteins. Although we suggest below that the nucleotide 
complexes reported here represent a state of incomplete recognition of the nucleotide by 
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the synthetase, interactions of the guanine base are identical to those of the synthetase 
in its complex with IMP, Mg^"^, GDP and succinate (unpublished results). 
Atoms of the ribose of guanine nucleotides do not interact directly with the syn­
thetase. The weak interaction between the synthetase and the ribose moiety follows the 
trend of p21'"''®, G,ai and EF-Tu. 
In comparison to p21'"'", G,ai and EF-Tu, each of which recognizes the polyphosphate 
group of guanine nucleotides by way of a significant network of hydrogen bonds (Ta­
ble 4.3), the synthetase in complexes reported here interacts weakly with the phosphate 
moieties of guanine nucleotides. As discussed below, the absence of Mg^"'" and/or IMP in 
these structures is probably the underlying cause of the poor recognition of the triphos­
phate group. In the complex of GDP, IMP, succinate and Mg^"*", the polyphosphate 
moiety is involved in an extensive network of hydrogen bonds. Unlike G-proteins, where 
the observed interactions of the polyphosphate group with Mg^+ and the protein con­
tribute significantly to the nanomolar dissociation constant, the polyphosphate moiety 
of GTP contributes little to the net affinity of the guanine nucleotide to the synthetase. 
Interactions involving the base of GTP are of primary importance in determining its 
affinity to the synthetase, as mutations in the region of the phosphate-binding loop have 
little effect on the Km of GTP [54]. Presumably the binding-energy of phosphate-protein 
interactions is used to drive large conformational changes in the synthetase. 
Guanine nucleotides adopt a conformation in their complexes with adenylosuccinate 
synthetase, that differ from that of guanine nucleotides in complexes of p21''''®, G,ai, 
and EF-Tu (Table 4.4). The most significant difference involves the torsion angle (7) 
between 04' and C5', which is -synclinal in the synthetase complex, but +synclinal in 
the G-protein complexes. Perhaps related to this difference in the angle 7 is a difference 
in puckering of the ribose ring. The ribose in the synthetase complex adopts a C3'-exo 
conformation as opposed to the C2'-endo conformation of other G-proteins (Table 4.4). 
At a resolution of 2.7 A the puckering of the ribose, however, is only inferred by the 
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Table 4.3 Comparison of guanine nucleotide interactions in adenylosucci­
nate synthetase, p21''''®, G,ai, and EF-Tu. Only donor-acceptor 
pairs between 2.4 and 3.5 A are listed." 
Ligand GppCp Mg^'^-GppNp Mg^''"-GppSp Mg''^+-GppNp 
atom synthetase p2i'-as Gial EF-Tu 
N2 D333 0D2 D119 0D2 
Wat 282 
D272 0D2 
Wat 402 
D139 0D2 
N1 D333 ODl D119 ODl D272 ODl D139 ODl 
06 K331 N 
S414 OG 
A146 N A326 N D139 ODl 
S174 OG 
N7 N116 ND2 N269 ND2 N136 ND2 
OlA A18 N T48 OGl 
T48 N 
S47 N 
T26 OGl 
T26 N 
02A Wat 367 Wat 172 Wat 403 Y47 OHl 
Wat 187 Wat 413 Wat 491 
Wat 170 Wat 475 
OIB G15 N S44 N G23 N 
K16 N K46 N K24 N 
K16 NZ K46 NZ K24 NZ 
H22 N 
02B G15 N S17 N S47 N T25 N 
K16 N Mg2+ S47 OG Mg2+ 
Wat 172 Mg2+ T25 OGl 
Wat 173 Wat 413 Wat 491 
S17 OG Wat 410 
OIG Wat 175 
Wat 189 
Wat 426 
02G Mg2+ Mg2+ era
 to
 
+
 
Wat 173 Wat 410 Wat 490 
T35 OGl T181 OGl 
T35 N T181 N 
Wat 413 
03G K16 NZ K16 NZ K46 NZ K24 NZ 
G60 N G203 N D21 N 
G84 N 
"Data here is based on structures from the Protein Data Bank with accession identifiers 5P21, 
IGIL and lEFT for p21'''", and EF-Tu, respectively. 
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Table 4.4 Comformational parameters (in degrees) for guanine nucleotides 
in complexes with the synthetase and G-proteins. Numbers for 
the synthetase are averages over the GppN, GppNp, and GppCp 
complexes with root-mean-squared deviations in parentheses. 
Parameter" Synthetase Mg2+-GppNp Mg^+-GppSp Mg2+-GppNp 
complexes p21'"" G,q1 EF-Tu 
X -96(3) -112 -116 -111 
vo 0(4) -20 -26 -20 
25(4) 39 36 30 
V2 -39(2) -41 -30 -31 
vz 39(3) 30 14 19 
-26(4) -6 8 0 
7 -59(4) 55 50 47 
P 199(6) 170 144 162 
^max 41(3) 42 37 33 
"Parameters are defined according to lUPAC convention [107]. 
X-ray data. The synthetase complex of GDP, IMP, Mg^"*", and succinate reveals GDP 
in a conformation that is nearly identical to the one reported here (unpublished re­
sults). The observed differences in nucleotide confomation in complexes of G-proteins 
and the synthetcise may stem from differences in the mode of recognition of Mg^+ by 
the synthetase relative to G-proteins (Silva et al.^ 1995). 
4.4.4 Conformational changes in the synthetase in response to guanine 
nucleotides. 
A plot (not shown) of the root-mean-squared deviations in atoms of the main chain 
between the guanine nucleotide complexes and the unligated enzyme in the P2i2i2i 
crystal form indicates only limited conformational change in the protein in response to 
guanine nucleotides. The changes are largest in the immediate vicinity of the guanine 
base (1.2 A root-mean-squared deviation for main-chain atoms of Pro''^'^) and in the 
disordered loops, involving residues 299-304 and 121-130. The loops are disordered in 
the unligated structure [101], and remain poorly ordered in the guanine nucleotide com­
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plexes. Differences in these loops are probably due to uncertainties in the interpretation 
of weak electron density. 
In preliminary complexes of the synthetase with GDP, IMP, and succinate 
(unpublished results), the enzyme undergoes large conformational changes (displacement 
of some a-carbons in excess of 10 A) in the region of binding of the guanine nucleotide. 
The conformational changes involve the loop, spanning residues 38 to 53. The absence 
of conformational change in the P2i2i2i crystal form may arise from 1) the inability 
of the synthetase to relax due to lattice contacts or 2) a requirement for IMP and/or 
Mg^"*" in combination with the guanine nucleotide to evoke a conformational response. 
Lattice contacts clearly impact on the guanine nucleotide site of chain B in the P2i2i2i 
crystal form. As discussed above, lattice contacts are probably responsible for the low 
occupancy of nucleotide here. The addition of guanine nucleotides to concentrations 
above 0.8 mM may disrupt lattice contacts in the vicinity of the nucleotide binding site 
of chain B, leading to the observed loss of resolution in X-ray diffraction. Nonetheless, 
conformational changes do not occur in chain A, even though lattice contacts are remote 
from the binding site of guanine nucleotides. The addition of IMP (2 mM) and Mg^+ 
(10 mM) to the P2i2i2i crystal form in the presence of 0.8 mM guanine nucleotide leads 
to a significant loss of resolution in X-ray diffraction. IMP is apparently necessary in 
conjunction with guanine nucleotides to evoke a conformational change. Kinetic studies 
indicate that IMP, GTP and Mg^"^ in combination promote the exchange of the "7-
phosphate" between bound GDP and bound IMP [43]. Thus, the conformational changes 
observed in preliminary structures of the synthetase in its complex with IMP and guanine 
nucleotides may occur only when the active site contains IMP, Mg^"*" and a guanine 
nucleotide. The complexes reported here, then, represent an incomplete recognition of 
the nucleotide by the enzyme, the complete recognition requiring the presence of Mg^"*" 
and/or IMP. 
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4.4.5 Abbreviations 
^Abbreviations: GppNp, guanosine-5'-(;0,7-imido)triphosphate; GppCp, guanosine-
5'-()0, 7-methylene)triphosphate; GppN, guanosine-5'-(/3-amino)diphosphate; GppSp, 
guanosine-5'-(/3,7-thio)triphosphate. 
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5 CRYSTAL STURCTURES OF ADENYLOSUCCINATE 
SYNTHETASE FROM ESCHERICHIA COLICOMPLEXED 
WITF GDP, IMP, FADACIDIN, NO3, AND Mg2+. 
A paper submitted to the Journal of Molecular Biology. 
Bradley W. Poland, Herbert J. Fromm and Richard B. Honzatko 
5.1 Abstract 
Crystal structures of adenylosuccinate synthetase from Esherichia coli complexed 
with Mg^"'", IMP, GDP, NO3 and hadacidin at 298 and 100°K have been refined to R-
factors of 0.198 and 0.206 against data to 2.8 and 2.5 A resolution. Bond lengths and 
angles deviate from expected values by 0.013 A and 1.87° for each of the structures. 
A 9 A conformational change occurs in the loop 42-53, which flanks the binding 
site for GDP. Loops 120-130 and 299-303, disordered in the absence of ligands, become 
ordered in their presence. The peptide linkages between residues 40-41 and 223-224 
reorient so that the main chain carbonyl of Gly 40 can coordinate to Mg^"^ and the 
backbone amide of 224 can hydrogen bond to NO J. 
Mg^"^ is five coordinated, with the possiblity of a sixth coordinate bond (at 3.3 A) 
to the side chain of Asp 13. Oxygen atoms from GDP, NO3, and hadacidin define the 
equitorial plane of coordination of the Mg^"*", while the backbone carbonyl of Gly 40 is 
the apical ligand. In addition to its coordination to Mg^+, NO J hydrogen bonds to Lys 
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16 and the backbone amides 13, 40 and 224. The nitrogen of NO3 is approximately 
2.7 A from 06 of IMP, reflecting a strong electrostatic interaction between the electron 
deficient nitrogen and the electron rich 06. The /0-phosphate oxygen of GDP, closest to 
NO3, is also coordinated to Mg^"*", suggesting an interaction between the /3,7-bridging 
oxygen of GTP and Mg^""" in the enzyme substrate complex. NDl of His 41 hydrogen 
bonds to one of the oxygens of the /3-phosphate of GDP and approaches one of the 
oxygens of bound NO3. The aldehyde group of hadacidin coordinates to the Mg^"*", 
while its carboxyl group interacts with backbone amides of residues 299 to 303 and the 
side chain of Arg 303. The 5'-phosphate of IMP interacts with Asn 38, Thr 129, Thr 
239 and Arg 143 (from a monomer related by twofold symmetry), whereas the base of 
IMP hydrogen bonds to the side chains of Gin 224 and Asp 13 through its N7 and N1 
positions, respectively. 
A mechanism is proposed for the two-step reaction governed by the synthetase, in 
which His 41 and Asp 13 are essential catalytic side chains. 
5.2 Introduction 
The first committed step in the de novo biosynthesis of AMP is the formation of 
adenylosuccinate from GTP, IMP and aspartate: 
GTP + IMP + L-aspartate GDP -|- P,- + adenylosuccinate 
Adenylosuccinate synthetase (IMP:L-aspartate ligase (GDP-forming), EC 6.3.4.4) from 
Esherichia coli is a Mg^'^ dependent enzyme that catalyzes the above reaction by a 
two step process [2] [5] [41] [42] [43] [61]: (i) the transfer of the 7-phosphate of GTP 
to the 6-oxygen of IMP to form a 6-phosphoryl intermediate and (ii) the nucleophilic 
displacement of the 6-phosphate group by aspartate to form adenylosuccinate. Other 
mechanisms have been proposed for the action of adenylosuccinate synthetase [32] [40], 
but all have the common feature of combining Mg^+, aspartate, IMP and GTP into a 
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single active site. The enzyme stabilizes a complex of three substrates and perhaps as 
many as two Mg^"^ [34] with conformational and spatial fidelity sufficient to catalyze 
a sequence of two reactions. In addition, adenylosuccinate synthetase has a narrow 
specificity with respect to substrates. Hydroxylamine will substitute for aspartate [2], 
2'-deoxy-IMP and /3-D-arabinosyl-IMP for IMP [31], and 2'-deoxy-GTP [23] and GTP-^S 
[61] for GTP. 
The demanding requirements of stereochemistry and substrate specificity are not un­
usual for enzymes in general. The active site of unligated adenylosuccinate synthetase, 
however, is disordered [81] [101]. Furthermore, the enzyme does not recognize the phos­
phate groups of guanine nucleotides in the absence of other substrates and Mg^"''[108]. In 
order to provide information with respect to the quintary complex of enzyme, aspartate, 
GTP, IMP, and Mg^"*", adenylosuccinate synthetase from E. coli has been crystallized in 
the presence of GDP, IMP, Mg^"^, NO3 and hadacidin. Hadacidin (Figure 5.1), a fermen­
tation product of Penicillium frequentans [109], is a competitive inhibitor (K,-,10~® M) 
with respect to aspartate [16] [21]; the only known function of hadacidin is the inhibition 
of adenylosuccinate synthetase [110]. Markham and Reed [16] have shown that NOJ and 
GDP synergistically inhibit adenylosuccinate synthetase, speculating that NO3 occupies 
the binding site for the 7-phosphate of GTP. 
Reported here are the crystal structures of the complex of adenylosuccinate syn­
thetase with GDP, IMP, Mg^"*", NO3 and hadacidin at temperatures of 298 and 100°K, 
refined against data to 2.8 A and 2.5 A resolution, respectively. The complex, regardless 
of temperature, reveals an ordered active site, with each ligand clearly defined by the 
electron density. The recognition of Mg^"*" by the synthetase is strikingly different from 
other GTPases [60] [97] [99] [105] [111]. The active site is organized about a Mg^"'", which 
coordinates GDP, NO3 and hadacidin. The spatial relationships between bound NO3, 
the 6-oxygen of IMP, and the nearest oxygen of GDP is consistent with the generation 
of PO3 or an "exploded" transition state in the first step of the reaction catalyzed by 
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Figure 5.1 Diagram of hadacidin showing chirality, covalent linkages and 
names of atoms. 
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the synthetase. Asp 13 could function as a catalytic base in the abstraction of a proton 
from the N1 position of IMP in the first step of the reaction and then act as a catalytic 
acid in the second step by the re-protonation of the N1 position of 6-phosphoryl-IMP. 
His 41 may be a catalytic acid, protonating an oxygen of the /3-phosphate of GTP in the 
first step and an oxygen of the putative 6-phosphoryl intermediate in the second step. 
5.3 Results and Discussion 
5.3.1 Quality of the refined models 
Models for ligated adenylosuccinate synthetase have been deposited with the Protein 
Data Bank, Brookhaven National Laboratory. The method of Luzzati [75] indicates 
an uncertainty in coordinates of 0.30 A. The amino acid sequence used in refinement 
is identical to that reported by Silva et al. [101]. Results of the refinement are in 
Table 5.1. A simplified view of one monomer of the synthetase dimer, as well as the 
major interactions between ligands and the protein are presented in Figure 5.2. Electron 
density eissociated with selected ligands appears in Figure 5.3 
The Ramachandran plot [112] for the low-temperature P3221 crystal form appears in 
Figure 5.4 (the corresponding plot for the room-temperature model is comparable). As 
in other crystal forms of the synthetase [81] [101], the most apparent outlier is Gin 10, 
which exists in the same conformation in each of the five independent polypeptide chains 
of three crystal forms. The program PROCHECK [103] indicates better stereochemistry 
for both the low- and room-temperature models, than is typical for a structure of 2.5 
A resolution. The model refined against data collected at low-temperature conforms 
more closely to ideal stereochemistry, than the model based on room-temperature data 
(Table 5.1). The low temperature data set is superior in nominal resolution [(I)=2o'(I) 
at 2.6 A relative to 3.1 A for the room temperature data]. A much improved electron 
density map is the most significant consequence of the superior data acquired at low-
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Figure 5.2 (Left) Diagram of a ligated monomer of adenylosuccinate syn­
thetase [drawn with MOLSCRIPT"], showing the binding sites 
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Table 5.1 Refinement statistics for adenylosuccinate synthetase. The GppN 
complex results from a soak of Mg^"^ (10 mM) and GppNp (0.8 
mM), the GppN/GppNp complex results from a soak of GppNp 
(0.8 mM) and the GppCp complex results from a soak of GppCp 
(0.8 mM). 
P3221 P3221 
298°K 100°K 
Resolution limit (A) 2.8 2.5 
Number of measurements 128898 118273 
Number of unique Refl. 17336 21607 
Completeness of data set (%) 99 99 
Completeness of data in 
the last resolution shell (%) 99(2.92-2.80A) 99(2.61-2.50A) 
P a 
^sym 9.4 8.9 
Number of refl. in refinement'' 14422 18787 
Number of atoms'^ 4640 5216 
Number of solvent sites 162 354 
R-Factor'' 0.188 0.209 
R-Free® 0.234 0.273 
Resolution (A) 5 to 2.8 5 to 2.5 
Mean B (A^) for protein 
chain A 31 25 
Rms deviations 
bond lenghts (A) 0.014 0.011 
bond angles (deg) 1.91 1.86 
dihedral angles (deg) 24.6 24.4 
improper dihedral angles (deg) 1.50 1.47 
12j IZi I < •'j >1 /Z)i Ylj where i runs over multiple observations of the same 
intensity, and j runs over all crystallographically unique intensities. 
''All data in the resolution ranges indicated. 
"^Includes hydrogens linked to polar atoms. 
actor = 53 II ^obs | ~ | ^calc II / 1 Fobs ji 1 -Fobj |> 0. 
" R f  a c t o r  based upon 10 % of the data randomly culled and not used in the refinement. 
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temperature. 
Superposition of room- and low-temperature structures reveal a root-mean-square 
deviation in the position of CA coordinates of 0.32 A. No a-carbon deviates in position 
by more than 0.81AA between the two structures. The average deviation between atoms 
of side chains is 0.57A. Even the sites for water molecules are generally in aggreement 
with 44% of water sites in the 298°K model falling within 1.0 A of water sites in the 
100°K model. Corresponding sites for waters show an overall root-mean-square deviation 
of 0.81 A. The root-mean-square difference in the coordinates of IMP, GTP, hadacidin, 
NO3 and Mg^"^ are 0.25 A comparable to the average level of uncertainty for the entire 
structure. 
The average thermal parameter as a function of residue in the low-temperature model 
varies from 9.3 A^ to 46.1 A^ for atoms of the main chain and 7.3 A^ to 48.5 A^ for 
atoms of side chains (Figure 5.5). The plot corresponding to Figure 5.5 for the room-
temperature model is qualitatively similar, but average thermal parameters for the main 
chain vary from 14.7 h? to 54.9 A^ and for side chains 11.9 A^ to 59.5 A^. As a 
consequence of the overall similarity of the room- and low-temperature models, the 
discussion below will focus on the low-temperature structure. 
5.3.2 Lattice and intersubunit contacts 
By far the most significant interface (^1 of Table 5.2) of the lattice is associated 
with a crystallographic twofold axis, which coincides with the molecular twofold axis of 
the synthetase dimer. As for the unligated structures [101], Lys 140, Arg 143, Arg 147, 
Asp 203, Asp 231, Tyr 235, Arg 257 and Arg 317 participate in numerous interactions 
between the subunits of the dimer. Chemical modification and directed mutation of 
residues 140 [67], 143 [113] [114] and 147 [77] inactivate the enzyme. The relationship 
between activity and Arg 143 is understandable in view of the interaction of Arg 143 
with the 5'-phosphate of IMP, bound to the symmetry-related subunit (see below). Lys 
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Figure 5.3 Electron density from a 2Fo6s-Fca!c map associated with GDP, 
Mg^^, NO3 and IMP from the 100° K complex. Contour level is 
6-0- with a cover radius of 1.0 A. 
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Figure 5.4 Distribution of angles for amino acid residues of the P3221 
crystal form. Letter o respresents glycine and x all other residue 
types. Significant outliers are labeled. 
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140 and Arg 147, however, are not in the active site. At low protein concentrations the 
synthetase exists as a monomer, aggregating to the dimer in the presence of IMP, GTP 
and Mg^"*" [114]. Chemical modifications of positions 140, 143 and 147 may occur when 
the synthetase is a monomer. Structural modifications at positions 140, 143 and 147 
may block aggregation to the dimer. If the dimeric state is required for tight binding of 
IMP (see below), then any mutation or chemical modification that disrupts the interface 
between monomers of the dimer will inhibit the synthetase. 
The other lattice interface (#2 of Table 5.2) involves only a few residues, the most 
significant of which belong to the loops 40-53 and 345-352. Loop 40-53 undergoes a 
large change in conofrmation in response to ligands (see below). The growth of P3221 
crystals may require the altered conformation of the synthetase, as the loop 42-53 is the 
one structural element of the unligated synthetase that cannot be accommodated in the 
lattice of the P3221 crystal form. 
5.3.3 Conformational changes 
The loop 42-53, which folds against the guanine nucleotide, exhibits the largest 
conformational change (Figures 5.6 & 5.7). The conformational change is triggered by 
interactions between bound Mg^"^ and the carbonyl oxygen of Gly 40, EIS well as the side 
chain of Asn 38 and the 5'-phosphate of IMP. In forming these interactions, relatively 
small conformational changes in the segment spanning residues 38 to 41 are amplified 
into a 9 A movement by a-carbons at the extreme end of the loop. The peptide linkage 
between residues 40 and 41 reorients in order to to coordinate the Mg^"*" (see below). 
In addition to the peptide linkage between residues 40 and 41, the linkage between 
residues 223 and 224 also reorients, so that the backbone amide 224 can hydrogen bond 
to one of the oxygens of the bound nitrate (see below). In the unligated structure both 
side chain and main chain atoms in the vicinity of residues 40-41 and 223-224 possess 
relatively high thermal parameters [101]. Conceivably even in the absence of ligands 
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Table 5.2 Lattice contacts of the P3221 crystal form". 
First residue Bridging Water*" Second residue 
Interface no. F 
Asn 70 0 Wat 543 Asp 231 ODl 
Wat 555 Asp 231 ODl 
Gly 71 0 Wat 555 Asp 231 ODl 
Asn 79 ND2 Asp 231 ODl 
Glu 101 OEl Wat 574 Leu 360 N 
Ala 102 0 Wat 543 Asp 231 ODl 
Asp 114 ODl Wat 631 Arg 143 NH2 
Arg 117 NHl Tyr 167 OH 
Lys 124 NZ Glu 163 OEl 
Lys 140 NZ Asp 231 ODl 
Wat 555 Asp 231 ODl 
Asp 231 0D2 
Val 141 0 Ser 240 OG 
Arg 143 NHl Val 238 0 
IMP 440 02A 
Arg 144 N Tyr 235 OH 
Gly 145 N Tyr 235 OH 
Gly 145 0 Tyr 235 OH 
Arg 147 NHl Asp 231 0 
Arg 147 NH2 Wat 506 Asp 231 0 
Wat 506 Gly 233 0 
Gly 149 0 Wat 661 Asp 364 ODl 
Lys 160 NZ Asp 363 0D2 
Tyr 167 OH Gin 171 NE2 
Asp 203 ODl Arg 317 NH2 
Asp 203 0D2 Arg 317 NH2 
Ser 205 OG Arg 317 NH2 
Wat 533 Arg 317 NH2 
Wat 533 His 232 NDl 
Asp 206 ODl Gin 320 NE2 
Asp 209 ODl Gin 320 NE2 
His 232 NE2 Thr 250 0 
Thr 244 OGl Wat 624 Ala 249 0 
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Table 5.2 (Continued) 
First residue Bridging Water*" Second residue 
Gly 246 N Wat 624 Ala 249 0 
Ala 249 0 Wat 500 Leu 321 0 
Gly 253 0 Wat 514 Gin 320 0 
Leu 254 0 Wat 500 Leu 321 0 
Gly 255 N Gin 320 0 
Arg 257 N Ser 323 OG 
Arg 257 NE Ser 323 0 
Ser 325 OG 
Arg 257 NH2 Ser 323 0 
Leu 324 0 
Ser 325 OG 
Tyr 258 OH Wat 667 Val 319 0 
Interface no. 2^^ 
He 45 0 Wat 623 Glu 354 N 
Glu 48 OEl Arg 348 NHl 
Wat 623 Glu 354 N 
GIu 48 0E2 Arg 348 NH2 
Wat 598 Glu 354 0E2 
Leu 69 0 Gly 352 N 
Glu 62 N Pro 350 0 
Asp 88 0 Wat 607 Tyr 372 N 
Arg 89 0 Arg 348 NE 
Arg 348 NH2 
Arg 96 NHl Wat 651 Gly 367 0 
Wat 651 Glu 369 OEl 
Arg 419 NHl Asp 351 0 
Arg 419 NH2 Asp 351 0 
"Contacts listed are less than 3.2 A. 
''If no bridging water is listed, then the atom of the left-hand column is in direct contact with 
the corresponding atom of the right-hand column. 
•^Interface between monomers of the dimer. Entries in the right-hand column come into contact 
with those listed in the left-hand column after applying the operator l—x,y—x,—z + 2/3 to their 
fractional coordinates. Entries in the left -hand column come into contact with those listed in the 
right-hand column after applying the operator —x,y — x, —z + 2/3 to their fractional coordinates. 
''Entries in the right-hand column come into contact with those listed in the left-hand column 
after applying the operator y—x, I—®, 2-1-1/3 to their frewitional coordinates. Entries in the left-hand 
column come into contact with those listed in the right-hand column after applying the operator 
1 — J/,z — t/4-1,2—l/3to their fractional coordinates. 
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these peptide linkages exist in more than one conformation. Another large and perhaps 
significant conformational change involves a rotation of 122° about of His 41, causing 
the rupture of the salt link between His 41 and Asp 21 of the unligated structure and the 
formation of a new salt link between His 41 and the ;(3-phosphate of GDP (Figure 5.7). 
In the unligated P2i crystal form residues 361-366 are well-ordered and in the same 
conformation in each monomer of the synthetase dimer [101]. In another unligated crys­
tal form (P2i2i2i), however, the conformations of residues 361-366 differ in each subunit 
of the dimer, only one of which resembles the well-defined conformation, observed in the 
P2i crystal form. The region 361-366 in the P3221 crystal form is similar in conforma­
tion to chain B of the P2i2i2i crystal form, being unlike the conformation observed in 
P2i crystals. Soans et a/. [80] observed differences in the solvent quenching of trypto­
phan fluoresence in the presence and absence of ligands. The region 361-366 contains 
one tryptophan (residue 365), the side chain of which is buried in the P2i crystal form, 
but exposed to solvent in the P3221 crystal form. The two different environments for the 
side chain of Trp 365 correlate well with observed fluorescence properties of the enzyme 
in the presence and absence of ligands. 
Other striking conformational changes implied by Figure 5.6 represent the "conden­
sation" of disorder into ordered structure. The loop 120-130 (described with respect 
to IMP interactions) and the loop 299-303 (described with respect to the binding of 
hadacidin/aspartate) are well-ordered in the P3221 crystal form as a consequence of 
specific protein-ligand interactions. 
Other conformational changes are modest, but show a systematic trend. The 10-
stranded ^-sheet that forms the central core of the monomer [81] [101] undergoes no 
conformational change. Structural elements which connect the strands of this central 13-
sheet collaspe toward the active site crevice. The movements of these structural elements 
range from as little as 1.0 A to as much as 12 A for the loop 42-53 (Figure 5.7). 
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of a-carbons between the unligated chain B of the P2i2i2i crys­
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H2 = Helix 2, L2 = loop 120-130, H5 = Helix 5, H6 = Helix6, 
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5.3.4 GDP binding site 
The polyphosphate moiety of GTP analogs is not recognized by the synthetase in 
the absence of other active site ligands [108]. The complex reported here reveals the 
same interactions at the guanine base as reported by Poland et al. [108], augmented by 
numerous interactions involving the diphosphate moiety of GDP (Table 5.3). Atom 06 
of GDP interacts with OG of Ser 414 and the backbone amide of Lys 331. Endocyclic 
N1 and exocyclic N2 of the base interact with the side chain of Asp 333. Due to 
conformational changes, which are in proximity to the GDP molecule, the 2'-0H of the 
ribose hydrogen bonds to a water molecule (Wat 574), which in turn hydrogen bonds 
to backbone carbonyls 42 and 417. In addition, the /3-phosphate interacts with the 
backbone amides 15, 16 and 17, as well as the Mg^"*" (Figure 5.8). The a-phosphate of 
GDP interacts with the Mg^"*" and the backbone amide 42. The hydrogen on NDl of 
His 41, after its significant conformational change, noted above, hydrogen bonds to the 
)3-phosphate. 
The guanine nucleotide, in spite of the conformational change in the loop 42-53 and 
the recognition of the polyphosphate moiety by the enzyme, is essentially identical in 
conformation to that reported by Poland et al. [108]. The torsion angle 05'-C5'-C4'-
C3' (7 by convention) is approximately -66° {-synclinal), the torsion angle 04'-Cl'-N9-
04 (x by convention) changes from -96° to -82® (anti) and the pseudorotation phase 
angle of the ribose changes from 199° to 163° (3'-ea:o). (Saenger [107] defines 7, Xi 
and pseudorotation phase angle.) The pseudorotation phase angle is not determined 
unambiguously, because of the limited resolution in the present and previously reported 
[108] nucleotide complexes. 
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Table 5.3 Selected contacts between ligand atoms and protein atoms. 
Ligand Ligand Atom Distance (A) Contact Atom" 
GDP 
N2 2.67 0D2 Asp 333 
N1 2.78 ODl Asp 333 
06 2.53 OG Ser 414 
3.31 N Gly 416 
3.10 N Lys 331 
02' 2.47 OW Wat 574 
2.54 OW Wat 801 
N3 2.83 OW Wat 600 
03' 3.10 OW Wat 801 
2.82 OW Wat 705 
02A 2.35 Mg2+ 
OlA 3.13 OW Wat 502 
3.12 N Thr 42 
2.54 OW Wat 666 
OIB 2.97 N Gly 17 
2.93 NDl His 41 
02B 2.28 Mg2+ 
3.08 NDl His 41 
03B 2.65 N Lys 16 
2.98 N Gly 15 
Mg2+ 
Mg2+ 2.28 02B GDP 
2.35 02A GDP 
2.57 02 Nitrate 
2.11 0 Gly 40 
1.98 0 Hadacidin 
Nitrate 
03 2.95 N Asp 13 
01 3.26 NZ Lys 16 
2.63 N Gin 224 
02 2.57 Mg2+ 
2.71 N Gly 40 
N3 2.72 06 IMP 
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Table 5.3 (Continued) 
Ligand Ligand Atom Distance (A) Contact Atom" 
Hadacidin 
0 1.98 Mg2+ 
OB 2.96 NH2 Arg 305 
2.78 0D2 Asp 13 
0D2 2.88 N Thr 301 
3.36 N Thr 300 
ODl 2.84 NH2 Arg 303 
IMP 
N1 2.59 ODl Asp 13 
06 2.72 N3 Nitrate 
N7 2.86 NE2 Gin 224 
02' 2.88 NH2 Arg 303 
2.81 0 Val 273 
03' 2.90 OW Wat 784 
2.62 OW Wat 584 
OlA 2.93 N Thr 129 
2.67 OGl Thr 129 
2.67 OW Wat 507 
02A 2.89 NHl Arg 143# 
2.61 OW Wat 601 
03 2.90 ND2 Asn 38 
2.82 OGl Thr 239 
N3 3.15 OW Wat 819 
"Contacts listed are less than 3.4A. 
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Figure 5.7 Stereoview of conformational changes as revealed by the super­
position of chain B of the P2i2i2i crystal form (dashed lines) 
onto the ligated crystal form (solid lines). The superposition is 
based on a-carbons of the lO-stranded /?-sheet that forms the 
structural core of the synthetase (bold lines). Labels are de­
fined as in Figure 5.6 and ligands are drawn with heavy lines. 
(Top) Conformational changes as represented by superimposed 
a-carbon traces. (Bottom) Conformational changes of the loop 
42-53, showing reorientations of backbone carbonyl 40 and the 
side chain of His 41 and interactions with Mg^^ and GDP which 
apparently drive the transformation. 
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5.3.5 IMP binding site 
Recognition of IMP by the synthetase is primarily through its S'-phosphate. OGl 
of Thr 129, backbone amide 129, ND2 of Asn 38, OGl of Thr 239 and the guanidinium 
group of Arg 143 of the symmetry related monomer all interact with the 5'-phosphate 
of IMP (Table 5.3 & Figure 5.9). In addition, three water molecules, Wat 587, 610 and 
601 mediate interactions between the 5'-phosphate and the protein. Arg 143 is the only 
residue contributed to the active site by the synmmetry-related monomer. Mutants Leu 
143 and Lys 143 each show 100-fold elevations in Km for IMP [114], thus confirming the 
significance of Arg 143 to the function of the synthetase. In addition, the 5'-phosphate 
of IMP along with the side chain of Asp 114 (conserved in all known sequences of the 
synthetase) lie at the N-terminus of helix H4 (Figure 5.2). No direct hydrogen bonds, 
however, exist between helix H4 and either Asp 114 or the 5'-phosphate. 
The 2 -OH group of the ribose of IMP hydrogen bonds to the quanidinium of Arg 303 
(Figure 5.9, Table 5.3). The interaction here must not have a stabilizing influence on the 
enzyme-IMP interaction as (i) 2'-deoxy-IMP works well as a substrate for the synthetase 
and (ii) a Leu 303 mutant, although elevating the Km for aspartate some 100-fold [59], has 
no effect on the Km of IMP. (Interactions between position 303 and hadacidin/aspartate 
are dicussed below.) Conceivably the decreased energy due to the formation of the Arg 
303-IMP interaction is offset by entropic penalties in freezing-out the conformation of 
the loop 299 to 303. The 3'-0H of the IMP ribose hydrogen bonds with Wat 784 and 
584, which in turn interact with backbone carbonyls 126 and 273, respectively. Although 
the data are not of sufficient resolution to unambiguosly determine the state of pucking 
of the ribose of bound IMP, the best fit to the electron density occurs with a low-energy 
2'-endo puckering (pseudorotation phase angle, 166°). The torsion angles 05 -05 -04'-
03' (7 by convention) and 04'-01'-N9-04 (x by convention) are 62° [+synclinat) and 
-135° (anti), respectively. 
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Interactions between IMP and OGl of Thr 129, backbone amide 129 and backbone 
carbonyl 126 are apparently critical to the transformation of loop 120-130 from a state 
of disorder [81] [101] into the well-defined conformation observed here. In addition, to 
the interactions described above, Asp 114, Glu 118 and Arg 303 hydrogen bond to loop 
120-130; these interactions are absent as well in the unligated synthetase. The binding of 
IMP, then, stabilizes the conformation of at least one of two elements of poorly ordered 
structure of the unligated synthetase. 
The base of IMP interacts with the amide side chain of Gin 224 through its N7 
position and with the side chain of Asp 13 through its N1 position. The interaction 
involving Asp 13 identifies it as a possible catalytic base in the abstraction of the proton 
from N1 of IMP (See discussion of mechanism below). The interaction involving Gin 224 
is relevant to reported differences in the recognition of IMP analogs by synthetase from 
mammals and leishmanial parasites [28] [115]. Unlike the synthetase from leishmanial 
parasites, mammalian synthetases require N7 of the purine base to be a proton acceptor 
in hydrogen bonds, as allopurinol ribonucleotide is not a substrate for the mammalian 
enzyme. Although sequence information for the synthetase from a leishmanial parasite 
is not available, the twelve known sequences of the synthetase have either a glutamine 
or an asparagine at positions equivalent to 224 of the E. coli enzyme. 
5.3.6 Hadacidin binding site 
Hadacidin (Figure 5.1) coordinates the Mg^+ through its aldehyde group and inter­
acts through its carboxylate with backbone amide 301 (Table 5.3 & Figure 5.10). The 
interaction of the carboxylate of hadacidin mimmicks the putative stabilizing influence 
of negative electrostatic charge placed at the N-terminal side of a-helices [116]. Residues 
299 to 303 are disordered in all unligated structures of the synthetase [81] [101] [108]. 
In the presence of hadacidin, however, the loop 299 to 303 adopts an ordered structure 
similar to a single turn of an a-helix. The dipoles of backbone amides 299-302 are 
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oriented toward the carboxylate of hadacidin. These interactions are complemented by 
an electrostatic interaction between that same carboxyl group and the side chain of Arg 
303. 
Atom NA of hadacidin is tetrahedral, inferring the absence of double bond char­
acter between it and the carbon of the aldehyde group. Attempts to refine a planar 
(amide type) nitrogen in hadacidin, with associated improper and dihedral restraints, 
resulted in planar geometry, but with severe distortions (30°) in three-center angles of 
the nitrogen. A search of the Cambridge Data Bank resulted in one fragment similar to 
hadacidin [117]. In that fragment the corresponding nitrogen has tetrahedral geometry. 
A tetrahedral nitrogen in hadacidin admits the possibility of two optical isomers. Only 
the D-chiral center (Figure 5.1) provided an acceptable fit to the electron density with 
good stereochemistry. 
Evidence to date suggests hadacidin is an analog of aspartate with respect to the 
catalytic action of adenylosuccinate synthetase: (i) Hadacidin is a competitive inhibitor 
with respect to aspartate [21] [16]. (ii) Directed mutation of residues in the segment 
299 to 303 elevates the of aspartate alone [59]. (iii) The enzyme recognizes the 
aspartate-Mg^"*" complex as its substrate, rather than aspartate alone [34]. Assuming 
that the carboxylate and aldehyde groups of hadacidin are structural equivalents of the 
/0-carboxylate and a-carboxylate of aspartate, respectively, one can model aspartate in 
the active site so that its amino group is within 3 A of C6 of IMP (Figure 5.10. The 
amino group of modeled aspartate hydrogen bonds with backbone carbonyl 38, the 13-
carboxylate retains approximately the same interactions as the carboxylate of hadacidin 
and the a-carboxylate interacts with both Mg^"*" and Arg 305. Atom OB of hadacidin 
and the amino group of modeled aspartate lie in opposite directions. Instead of being in 
proximity to C6 of IMP, OB of hadacidin hydrogen bonds to Arg 305. The interaction of 
OB may be a significant factor in hadacidin's high affinity (K,-, 10~® M) to the synthetase 
relative to aspartate (Km, 10"^ M). Not only does OB of hadacidin promote energy-
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stabilizing interactions, it also avoids an unfavorable nonbonded interaction with C6 
of IMP. In the ceise of modeled aspartate, one of the oxygens of its a-carboxylate can 
interact with Arg 305, as the second oxygen coordinates to Mg^+, but these favorable 
interactions will still be offset by possible steric interactions between the aspartate amino 
group and C6 of IMP. Apparently the synthetase recognizes hadacidin differently than 
aspartate. Hadacidin is not ELS much an analog of aspartate as it is a superior complement 
to the steric and electrostatic environment of the aspartate binding site of the synthetase. 
The above may account for the lack of inhibition by hadacidin of other enzymes that 
use aspartate as a substrate [110]. 
5.3.7 binding site 
Five atoms (backbone carbonyl 40, oxygens of the a- and (5- phosphates of GDP, an 
oxygen of NO3 and the aldehyde oxygen of hadacidin) are within a distance of 2.6 A 
of the Mg^"*" (Table 5.3 & Figure 5.11). A sixth atom, ODl of Asp 13, is 3.3 A from 
the Mg^"*", significantly beyond the expected distance of aji inner sphere ligand. Thus, 
the Mg^"^ exhibits square pyramidal coordination. In preference to a strong interaction 
with the Mg^"^, Asp 13 apparently favors a hydrogen bond to N1 of IMP and to OB of 
hadacidin. On the basis of these data alone we cannot determine whether the distorted 
octahedron exhibited by the magnesium-enzyme complex stems from the influence of 
hadacidin. We observe, however, in preliminary structures in the absence of hadacidin, 
the same departure from octahedral symmetry about the Mg^"^. A possible role for 
a five-coordinated Mg^"*" in the mechanism is discussed below. If NO3 in the present 
structure reports the location of the phosphate group of 6-phosphoryl-IMP, then after 
the first step of the reaction, Mg^"*" will interact with all three substrates/intermediates 
simultaneously. In addition to a possible catalytic role, then, Mg^"*" apparently plays a 
significant structural role in holding together the substrate/intermediates prior to the 
second reaction (attack of the amino group of aspartate on C6 of 6-phosphoryl-IMP). 
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The location of Mg^"'" relative to the enzyme, GDP and NO3, differs significantly 
from the relative position of Mg^+ in complexes of G-proteins [60] [97] [99] [105] [111]. 
His 41 of the synthetase, in fact, occupies the corresponding position of Mg^"*" observed 
in G-proteins. Kang and Fromm [34] claim that Mg^"*" coordinates to aspartate, a finding 
in harmony with the current structure, and that two magnesium ions are involved in the 
rate limiting step of catalysis. A possible second binding site for Mg^"*" may be the site 
currently occupied by His 41 (See discussion of mechanism below). 
5.3.8 Nitrate binding site 
NO3 and GDP synergistically inhibit adenylosuccinate synthetase, an effect at­
tributed to the interaction of NO J with the binding site for the 7-phosphate of GTP 
[16]. Oxygens of NO3 hydrogen bonds with the backbone amides 13, 40 and 224, as well 
as to the Mg^"*" and the side chain of Lys 16 (Table 5.3, Figure 5.12) NDl of His 41 is 
approximately 3.9 A away from an oxygen of NO3, perhaps indicating a potential for a 
hydrogen bond interaction. The density associated with NOj (Figure 5.3) clearly defines 
the orientation of the molecule. The normal to the least squares plane of NO J is 20° 
away from the line connecting the nitrogen of NO3 to 06 of IMP. The line connecting 
the closest oxygen of GDP (atom 02B) to the nitrogen of NOj makes an angle of 51° 
with respect to the same normal. Atom 02B of GDP and 06 of IMP are, respectively, 
3.1 and 2.7 from the nitrogen of NO3 . The close approach of the nitrogen of NO3 to 06 
of IMP is indicative of a strong electrostatic interaction between the electron deficient 
nitrogen and the electron rich oxygen. In fact, by virtue of the hydrogen bond between 
N1 of IMP and Asp 13, IMP could be in its tautomeric state, with 06 assuming a formal 
electrostatic charge of -1. 
NO3 defines an anion binding site which recognizes three oxygen atoms. If orthophos-
phate is positioned so that 3 of its 4 oxygens take up the positions of the 3 oxygens of 
NO3, the P atom will fall within 3.2 A of 06 of IMP or 2.8 A of the 02B of GDP. 
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As the typical phosphate ester linkage is approximately 1.6 A, the interactions defined 
by the oxygens of NO3 are probably the same as for the 7-phosphate of GTP and the 
phosphate group of 6-phosphoryl-IMP. Thus, the present complex can be used to model 
the initial GTP complex as well as the 6-phosphoryl-IMP intermediate complex. These 
models are discussed in relation to the mechanism of the synthetase (see below), but the 
GTP model is relevant as well to work of Poland et al. [108]. The phosphate moiety of 
j0,7-methylene-GTP is not recognized by the synthetase in the presence or absence of 
Mg^""". The failure of /9,7-methylene-GTP to be an analog of GTP may rest with the 
recognition of the y0,7-bridging oxygen by in the model for the GTP complex. 
5.3.9 Relevance of structure to the putative mechanism 
A schematic for the putative reaction mechanism of the synthetase appears in Fig­
ure 5.13, in which we have depicted a two step reaction consistent with the vast majority 
of the literature [5]. The first step can be viewed either as a nucleophilic attack of the 06 
of IMP on the 7-phosphate of GTP (associative, Sjv2 mechanism) or as the generation of 
the strong electrophile (PO3), which in turn attacks 06 of IMP (dissociative, Sjvl mech­
anism). The crystallographic data cannot eliminate either mechanism for the first step. 
The literature relevant to the synthetase generally depicts a nucleophilic displacement 
mechanism for the first step, but no data regarding kinetic isotope eff'ects are available. 
One would expect both base- and acid- catalysis in an associative (Sjv2) mechanism. 
Asp 13 hydrogen bonds to N1 of IMP (donor-acceptor distance of 2.6 A), making it a 
likely candidate in the abstraction of the proton from N1 of IMP. In addition. His 41 
may function as a catalytic acid. NDl of His 41 hydrogen bonds to the /3-phosphate and 
is within 1 A of hydrogen bonding to NO3. Protonation of the ;S-phosphate early in the 
reaction would stabilize the developing negative charge on that group. The likely roles of 
Mg^"*" are (i) stabilization of developing negative charge on the /3,7-bridging oxygen, (ii) 
activation of the 7-phosphorus atom by polarization of oxygens of the 7-phosphate and 
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(iii) assembly of key reactants into effectively an intramolecular reaction [118]. Mg^+ is 
coordinated to NO3, as well as the a-phosphate and the jS-phosphate groups of GDP. 
Thus, probably will coordinate one oxygen of the "7-phosphate", whether it is a 
part of GTP or 6-phosphory-IMP. 
The suggested roles for His 41 (catalytic acid) and Mg^"*" (charge neutralization and 
structural organization) are consistent as well with a dissociative (S/^1) mechanism. His 
41 would in that case initiate the reaction by protonation of the /3-phosphate. As noted 
above the nitrogen of NO3 is approximately 2.7 A from 06 of IMP and 3.1 A from 
the closest oxygen of GDP. Apparently, the active site can accommodate an "exploded" 
transition state, in which the bond between the 7-phosphorus and the /3,7-bridging 
oxygen is almost completely broken prior to covalent bonding with 06 of IMP. 
The second step of the reaction can be viewed as either a nucleophilic displacement 
of the 6-phosphoryl group by the attack of the amino group of aspartate or as the 
generation of an electrophilic center at C6 of 6-phosphoryl-IMP by the protonation of 
Nl. Presumably when the a-carboxylate of aspartate coordinates to Mg^"*", the zwit-
terionic character of the amino acid is lost, and the amino group of aspartate will also 
deprotonate. For the resulting neutral amino group to be an effective nucleophile, a 
second proton need be removed by a catalytic base. The only groups available for the 
abstraction of a proton from the amino group of aspartate are backbone carbonyl 38 or 
the /3-carboxylate of the substrate itself. The carbonyl group is a poor catalytic base 
and the ^-carboxylate of aspartate is involved in hydrogen bonding interactions, which 
require each of its oxygens to be proton acceptors. Thus, no likely group is available for 
the abstraction of a proton from the amino group of aspartate. 
The alternative to a nucleophilic displacement mechanism for the second step requires 
the protonation of Nl of 6-phosphoryl-IMP. Asp 13, whether the first step is SN2 or Sjvl, 
will receive the proton originally associated with Nl of IMP. The carboxylate of Asp 
13 is 2.6 A away from Nl of the IMP in the present structure and 3.3 A from Mg^"*". 
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If the carboxylate of Asp 13 coordinates to it then becomes a strong acid; its 
proton will move back to N1 of the 6-phosphoryl intermediate. By protonating NI of 
6-phosphoryl-IMP, one has generated the resonance equivalent of a carbonium ion at 
C6. This powerful electrophile will react with a suitably positioned atom, which on the 
basis of model building is the amino group of aspartate. His 41 could act as an acid 
catalyst in the second reaction by protonation of the 6-phosphoryl group. 
The above alternative begs the question: How is it that Mg^"*" should want to co­
ordinate a protonated side chain of Asp 13, when in the present structure that same 
Mg^"*" does not coordinate Asp 13 in its presumably ionized state? We cannot provide 
a certain answer to this question. Possibly in the formation of the 6-phosphoryl inter­
mediate, small conformational changes occur so that Asp 13 becomes coordinated to 
Mg^""". Alternatively, the presence of aspartate (rather than hadacidin) might alter the 
conformation of the enzyme so as to allow coordination of Asp 13 to Mg^+ after the 
6-phosphoryl intermediate forms. Finally, Kang and Fromm [34] suggest that two Mg^"'" 
are involved in the rate limiting step. As noted above, the observed in the present 
structure does not occupy a site homologous to that of G-proteins. Instead the side 
chain of His 41 occupies the observed binding site for Mg^"*" in other GTPases. Perhaps 
the role of His 41 as a catalytic acid is necessary only for the first step of the reaction. 
In order to drive the second step, another Mg^"*" coordinates the 6-phosphoryl group 
of the intermediate. The increase in positive charge at the 6-phosphoryl group could 
drive the other Mg^"*" (the one actually observed in the structure) from a state of five 
coordination to a state of six coordination, with the carboxylate of Asp 13 becoming 
the sixth ligand. We do not observe Mg^^ bound to this putative second site, perhaps 
because our concentration of free Mg^"^ is too low or because we have not formed the 
6-phosphoryl intermediate in the present structure. 
The mechanism proposed above should be regarded only as a basis for future exper­
iments. We note, however, in regard to the predicted importance of His 41 and Asp 
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13, that Ala 13 and Ala 41 mutants have no detectable activity (unpublished results). 
Thus, certain aspects of the proposed mechanism are certainly valid. 
5.4 Materials and Methods 
Adenylosuccinate synthetase was prepared as described previously from a genetically 
engineered strain of E. coli [12] [101]. The protein migrates as a single band on SDS-
polyacrylamide gel electrophoresis with an apparent relative molecular weight of 48,000. 
Conditions for the growth of the P3221 crystal form were discovered by use of the 
sparse matrix of Jancarik and Kim [86] and the method of hanging drops. Droplets 
contained 2 fi\ of enzyme solution [imidazole (50 mM), succinate (75 mM), GDP (4 
mM), NOj (8 mM), hadacidin (5 mM) and protein (10 mg/ml), pH 7.0] and 2 /il of a 
crystallization buffer [ polyethylene glycol 8000 (13% w/w), cacodylic acid/cacodylate 
(pH 6.5, 100 mM), and magnesium acetate (200 mM)]. Wells contained 500 fA of the 
crystallization buffer. Crystals of approximately 0.5 mm in all dimensions and belonging 
to the space group P3221 (a=b=81.42 and c=158.71 at 298°K and a=b=80.82 and 
c=159.03 at 100°K) grew in about one week. The asymmetric unit consists of a monomer; 
crystallographic and molecular twofold axes coincide. 
Data from the P3221 crystal form were collected on a Siemens area detector at Iowa 
State University and were reduced by using XENGEN [87]. The data set was 99% 
complete to 2.5 A resolution (Table 5.1). 
The structure of the P3221 crystal form was determined by molecular replacement, 
assuming initially a space of either P3i21 or P3221. Using programs from the CCP4 
package and the model for the unligated synthetase dimer [81] [101], structure factors 
were calculated for the synthetase dimer in an over-sized orthogonal unit cell (space 
group PI, a=b=c=150 A). The calculated structure factors were used in conjuction 
with the native data reduced in the space group P3i/P32 in the computation of a rota­
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tion function [70] [119]. The rotation function revealed a symmetry unique peak (a=65, 
/3=85, and 7=190) at a level of 12<r. The next highest peak in the map appeared at a 
level of 3(7. After applying the appropriate rotation to the coordinates of the original 
model, a translation function [88] was generated using the entire dimer in the space 
groups P3i and P32. Only the translation function calculated in the space group P32 
gave a well-defined peak at x=0.9576, y=0.2915, and z=0.0 (The structure determina­
tion in the space group P3i21/P3221, using a monomer of the synthetase as the trial 
structure, gave a correct solution to the rotation function, but gave ambiguous results 
with respect to the translation function in the space group P3221 and P3i21. Our suc­
cess in the space group of lower symmetry, using the dimer as the trial structure, may 
be a consequence of reduced noise in the translation function due to the removal of 
a larger set of intramolecular vectors.) The molecular replacement solution exhibited 
no unacceptable contacts. Using XPLOR [74], the rotated and translated dimer was 
refined as a rigid body against data to 5.0 A resolution in the space group P32. The 
initial R-factor was 0.40 and droped to a final value of 0.28 after 5 cycles. Rigid body 
refinement was repeated, extending the resolution of the data by increments of 1.0 A to 
a final resolution of 3.0 A. The model was subjected then to a single round of simulated 
annealing, during which the system was heated to 2000° K and then cooled to 300° K in 
steps of 25° K. The R-factor after the initial round of simulated annealing was 0.25 to 
3.0 A resolution. 
Although the diffraction data were consistent with a space group of higher symmetry 
(P3221 rather than P32), the dimer reported out of the first round of simulated annealing 
had significant differences in the conformation of the two monomers. The differences 
were in the region of the active site, corresponding to electron density associated with 
bound ligands and elements of the polypeptide chain that were disordered in the unli-
gated structures. We decided, therefore, to remain in the space group P32, interpreting 
the electron density of each subunit independently. After the ligands and polypeptide 
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were built into the electron density, each monomer of the dimer was subjected to non-
crystallographic restraints, which were similar in magnitude to force constants placed 
on covalent bonds. The strict enforcement of noncrystallographic symmetry actually led 
to a modest decline in the R-factor, confirming again that the proper space group was 
of higher symmetry, P3221. The dimer was translated along the z-axis to a position 
consistent with the space group P3221 and the refinement was completed. 
Refinement of the structures involved mannual fitting of models to the electron den­
sity, using a Silicon Graphics 4D-25 and the program TOM [73], followed by a cycle 
of refinement using XPLOR on a Silicon Graphics 4D-35. Constants of force and ge­
ometry for the protein came from Engh & Huber [89]. The geometry of hadacidin was 
was based on a related structural fragment, retrieved by a search of the Cambridge 
Data Base. Models of hdacidin with a planar nitrogen and with tetrahedral nitrogens 
in L- and D-configurations were refined individually. In early rounds of refinement both 
crystal strutures were heated to 2000°K and then cooled in steps of 25°K to 300°K. 
In later rounds of refinement, the systems were heated to 1000 or 1500°K, but then 
cooled in steps of 10°K. After the slow-cooling protocol was completed (at 300°K), the 
models were subjected to 120 steps of conjugate gradient minimization, followed by 20 
steps of individual B-parameter refinement. Individual B-parameters were subject to 
the following restraints: nearest neighbor, main chain atoms, 1.5 A^; next-to-nearest 
neighbor, main chain atoms, 2.0 A^; nearest neighbor, side chain atoms, 2.0 A^; and 
next-to-nearest neighbor, side chain atoms, 2.5 A^. 
Water molecules were added if (i) electron density at a level of 2.5(r was present in 
maps based on Fourier coeflacients (|Fobs| — |Fcaic|)e'""'"= and (2|Fobs| — |Fcaic|)e'°"'S and 
(ii) acceptable hydrogen bonds could be made to an existing atom of the model. If after 
refinement a site for a water molecule fell beyond 3.3 A from its nearest neighbor, that site 
was omitted from the model. In addition, water molecules were deleted from the model 
if their thermal parameters exceeded 80 A^. Harmonic restraints (50 kcal/mol) were 
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placed on the positions of oxygen atoms of water molecules, in order to allow new water 
molecules to relax by adjustments in orientation. Occupancies of water molecules were 
not refined, because of the high correlation between occupancy and thermal parameters 
for data of a nominal resolution of 2.0-2.5 A. Thus solvent sites with B values between 
50 A^ and 80 A^ probably represent water molecules with occupancy parameters below 
1.0 and thermal parameters substantially lower than those reported from the refinement. 
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6 CONCLUSION 
6.1 Adenylosuccinate synthetase from E. coli 
Crystal structures of the adenylosuccinate synthetase from Esherichia coli in the 
space groups P2i, P2i2i2i, and P3221 have been presented in this dissertation. The 
P2i crystal form revealed the structure of unligated adenylosuccinate synthetase from 
E. coli and allowed the modeling of GTP in the putative active site. The conformation 
of loops flanking the putative active site could not be unambiguously determined in this 
structure. The gradual infusion of ligands into this crystal form caused the crystal to 
crack or become disordered. 
After an extensive search of crystallization condition, the P2i2i2i crystal form was 
found. The structure of the unligated synthetase in the P2i2i2i crystal form was iden­
tical to that in the P2i crystal form. However, gradual infusion of GTP in this crystal 
form did not adversely affect the crystals and allowed the GTP binding site to be un­
ambiguously determined. 
The P2i2i2icrystal form was not suitable for use in determining other ligand binding 
sites. Another extensive search yielded conditions favorable for the structure determi­
nation of the fully ligated adenylosuccinate synthetase. The crystal structure of fully 
ligated adenylosuccinate synthetase, P3221 form, has described the IMP, Mg^"*" As­
partate, and GDP binding sites. Adenylosuccinate synthetase undergoes a large (QA) 
conformational change in one of the loops flanking the active site. The conformation of 
other loops flanking the active site, previously disordered, are now well defined. 
144 
A limited amount of kinetic data on mutations in adenylosuccinate synthetase from 
E. coli have been explained by this structure. However, issues related to the specific 
mechanism of catalysis are still ambiguous. Evidence does exist that indicate an "ex­
ploded" transition state in the formation of the 6-phosphoryl-IMP intermediate. 
Thus, the structures presented here have given a large quantity of useful information 
concerning the structure of adenylosuccinate synthetase from E. coli in the presence and 
absence of ligands. Evidence for the formation of the 6-phosphoryl-IMP intermediate 
and the mechanism by which it could be formed has been presented here. The general 
discussion of the reaction mechanism has also been addressed. 
6.2 Further work 
The structures presented here will serve as the starting point for further research 
focussed on i) trapping the 6- phosphoryl-IMP intermediate, ii) determining the mode 
of binding of adenylosuccinate, iii) locating the second Mg^"*"binding site, iv) determining 
the structure of kinetically interesting mutants and v) designing specific inhibitors for 
adenylosuccinate synthetase that could be used as chemotheropeutic agents. 
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